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Two manuscripts based on the work reported in this thesis 
were submitted and accepted for publication, the abstracts 
of which follow: 
SOLUBLE AND PARTICULATE FORMS OF MUSCLE ALKALINE PROTEINASE 
SHOW DIFFERENTIAL SENSITIVITY TO ENDOGENOUS INHIBITOR(S) 
Firhaad Ismail and Wieland Gevers 
(Biochemistry International, In Press) 
Membrane-free washed myofibrils derived from rat skeletal 
muscle homogenates contained a chymostatin-sensitive protease(s ) 
which acted on associated myofibrillar proteins, at an optimum 
pH of 8.5, much less rapidly at low ionic strength (insoluble 
myofilaments) than at high salt concentrations (solubilized 
proteins). When the myofibrillar fraction was added to the 
particle-free cytosol prepared from the muscle extracts, 
proteins of the cytosol were also degraded, but the activity 
in this case was much more pronounced at low ionic strength. 
This was because inhibitor(s) of the proteinase present in the 
cytosol fraction were only effective at high ionic strength 
when all the myofibrillar (and associated) proteins were in 
solution. 
The protease was separated from the bulk of the myofibrillar 
proteins by gel chromatography at high ionic strength. On 
dialysis against a low-salt buffer, part of the enzyme was 
Vi 
precipitated. The putative cytosolic inhibitor(s) were 
again only effective on the soluble enzyme at high ionic 
strength. 
A HIGH MOLECULAR WEIGHT CYSTEINE ENDOPEPTIDASE FROM RAT 
SKELETAL MUSCLE 
Firhaad Ismail and Wieland Gevers 
(Biochim. Biophys. Acta, In Press) 
A cytosolic enzyme of high molecular weight (about 500000), 
which attacks native or denatured proteins (inter alia casein, 
globin and hexokinase) was purified about 1000-fold from 
mixed rat skeletal muscles, including muscles freed of mast 
cells by prior treatment of the animals with the degranulator, 
compound 48/80. Peptides of varying size were generated from 
radio-actively labelled globin, but no free amino acids were 
formed; free tyrosine was also not released from azocasein. 
The pH optimum was 7.5 and the presence of an essential 
cysteine group was suggested because dithiothreitol (1 mM) 
stimulated the activity and N-ethylmaleimide (5 mM) and 
p-chloromercuriphenylsulphonic acid (1 mM) were inhibitors. 
The activity was markedly inhibited by zn
2
+ but not by leu-
peptin, chymostatin or pepstatin. The enzyme was stabilized 
by ATP, at concentrations as low as 0.1 mM, against inactiva-
tion at 42°C. The endopeptidase was clearly separated on 
gel chromatography from another large protease, also sensitive 
to Zn 2+, but with marked aminopeptidase activity and the 
properties of Hydrolase H. 
vii 
The activity levels of the protease, assayed after chromato-
graphy on Sepharose 68 of high-speed supernatant fractions, 
did not vary significantly in skeletal muscle samples which 
were derived from denervated, starved, diabetic or hyper-
thyroid animals, in all of which the abnormal physiological 
states expressed themselves as enhanced rates of tyrosine 
release by incubated soleus and extensor digitorum longus 
muscles. Nevertheless, the enzyme described here may be 
part of an ATP-dependent, multi-component proteolytic system 
similar to that already known to be present in reticulocytes. 
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The term "protein degradation" describes one or more catab-
olic processes by which native proteins are converted in the 
organism to constituent amino acids. 
It would perhaps be fair to state that our current under-
standing of this important area of cell metabolism is roughly 
at the stage which preceded the discovery of ribosomes in the 
pathway of protein biosynthesis. 
Some of the major aims of those working towards an under-
standing of intracellular protein degradation are (a) to 
provide information on the importance of this process to 
the overall viability of cells or organisms; (b) to identify 
the nature and location of individual reactions and the rate-
limiting steps in the degradative sequence; (c) to resolve 
differences between the catabolism of intracellular proteins 
and those extracellular proteins that are taken into the cell; 
(d) to discover the means by which the degradation of a single 
protein can be altered, since different proteins have differ-
ing rates of degradation; (e) to identify the component(s) 
and mechanisms underlying the energy requirement of the 
degradation process, and (f) to examine the biochemical, 
endocrinological and pharmacological controls of the process 
with the eventual aim to manipulate these controls and thus 
restrict disease states and other disadvantageous conditions. 
A review therefore, of muscle protein degradation and, more 
3 
specifically, of recent data obtained from in vitro animal 
studies, is prov i ded in this Chapter, outlining some of the 
major advances in this field and finally defining the specific 
objectives of the author, in the context of the above general-
izations. 
1.2. PATHWAY(S) OF INTRACELLULAR PROTEIN DEGRADATION 
1.2.1. Endocytosis, pinocytosis and membrane recycling 
Lysosomes are generally considered to be the major site of 
intracellular digestion of externally derived proteins. 
Such proteins are "captured" by cells through endocytosis 
or by pinocytosis, processes in which bound proteins or 
entire droplets of extracellular fluid, respectively, are 
internalized in vesicles derived from invagination of the 
plasma membrane (Dean, 1975). Fusion of these vesicles 
with primary or secondary lysosomes results in the exposure 
of the "captured" proteins to the lysosomal proteases and 
thus to their complete intralysosomal digestion to the level 
of amino acids (Ashford and Porter, 1962). Both these 
processes involve the internalization of membrane material 
(Dean, 1978). Since the usual fate of endocytic vesicles 
and their contents is fusion with the lysosomes, it was 
assumed for many years that the incoming membrane was digested 
together with its contents. It is now evident that in some 
mammalian cells at least, much of the membrane escapes degra-
dation and is returned to and inserted into the plasma 
membrane (Tulkens ~ ~' 1978): Fibroblasts were allowed 
4 
to endocytose and accumulate goat (antirabbit) IgG, 
following which surface antigens were tagged with rabbit 
antiplasma membrane IgG. Trapping of antiplasma membrane 
IgG was observed in lysosomes as well as at the cell surface -
consistent with the internalization of surface antigens by 
endocytosis, followed by their recycling to the cell surface. 
The mechanism whereby membrane is removed from and subse-
quently reinserted into the plasma membrane is not yet under-
stood. A process of budding, whereby a small vesicle is 
formed and discharged from the parent vacuole, seems the 
likely possibility (Dean, 1978). This kind of reinsertion 
into the plasma membrane clearly requires an interaction 
between the cytoplasmic face of the surface membranes and 
the returning membrane components. A frequently observed 
pattern is a sequence of fusion events, first between small 
pinosomes and subsequently between lysosomes and the larger 
pinocytic vacuole. It has been suggested (Lloyd and 
Williams, 1978) that these sequential vesicle fusions may 
provide the occasion for the budding process to take place 
with minimal energy requirements. When any two intracel-
lular vacuoles fuse together, the resulting vacuole will 
comprise, at the moment of fusion, the combined membrane 
and volume of the parent vacuoles. In the new vacuole thus 
formed there will be more membrane than is required to sur-
round the combined volumes of the two component vacuoles. 
Resumption of turgidity must involve either the influx of 
water or the loss of membrane. Uptake of water would 
aggravate water balance in a pinocytosing or endocytosing 
5 
cell and hence the alternative of membrane loss appears 
more attractive. It would not only avoid the problem of 
water balance but furthermore the energy requirement for 
the membrane movements necessary for budding would be less 
if the parent vacuole had excess membrane than if it was 
turgid (Lloyd, 1980). Budding from pinocytic vacuoles or 
secondary lysosomes into the cytoplasm followed by an exo-
cytic reinsertion into plasma membrane could represent a 
pathway for the recycling of plasma membrane components 
without degradation and resynthesis of membrane components 
(Fig. l.l(a)) (Dean, 1978). 
l .2.2. Lysosomes and autophagy 
Internalization of non-lysosomal material into lysosomes is 
believed to occur either by "classical autophagy
11 (Dean and 
Barrett, 1976) or by 11 microautophagy
11 (Pfeifer, 1981). 
"Classical autophagy 11 : An area of cytoplasm newly surrounded 
with membrane, is considered to fuse with a primary or secon-
dary lysosome, which are smaller vesicles containing hydro-
lytic activities. Digestion then occurs in the autophagic 
vacuole, with eventual reduction in organelle size until a 
secondary lysosome is formed. This lysosome is generally 
indistinguishable from a primary lysosome, and is able to 
fuse again and repeat the cycle (Fig. 1 .2). The digestion 
of intracellular proteins by this system is referred to as 
"autophagy", in contrast with the uptake and digestion of 





Plasma membrane recycling 
lntralysosomal membrane recycling 
A - Endocytosis 
B - Division to form one large and several small vesicles, alternatively 
a similar division may occur after the endocytic vesicle has fused 
(C) with a 1ysosome (L) 
D - Small vesicles fuse with plasma membrane, thus recycling membrane 
E - Lysosome invaginates to take in cytoplasmic material 
F - Division of the vesicle 
G - Fusion of small vesicles with lysosomal membrane (recycling) 
H - Disintegration of lysosomal membrane and both lysosomal membrane and 






A double membrane is shown enclosing a portion of cytoplasm 
(1) to form a vacuole (2). This fuses with a primary or 
secondary lysosome (5) to produce an autophagic vacuole (3). 
Digestion of intravascular contents continues (4) until 
complete, with the breakdown products passing out of the 
organelle, which is then reduced in size and becomes a 
secondary lysosome. 
8 
called "heterophagy". It is notable that endocytosed 
macrophage proteins are degraded in a population of macro-
phage lysosomes which are in at least some ways distinct 
from those degrading endogenous proteins, since lysosomo-
tropic agents (likd chloroquine) inhibit the degradation 
of the endocytosed proteins far more than that of the 
endogenous proteins (Poole~~. 1977). By means of 
quantitative electron microscopy, a number of results have 
been gathered, which indicate that changes in the volume 
fraction of autophagic vacuoles most often correspond to 
changes of protein degradation as determined by biochemical 
methods. Such results have been most often discussed in 
the light of the stimulation of cellular autophagy and 
protein degradation by glucagon (Woodside~~. 1974; 
Arstila et al, 1974) and in the case of amino acid depriva-
tion (Woodside et al, 1974). Inhibition of autophagy and 
of protein degradation has been noted after insulin admin-
istration (Mortimore and Mondon, 1970), during diurnal 
-
variation in food intake (Vidrich et al. 1977) and in the --
recovery period after protein depletion or starvation (Conde 
and Scornik, 1976). 
Microautophagy: This is an alternative mechanism proposed 
for lysosomal degradation of non-lysosomal proteins. The 
lysosomal membrane is believed to invaginate and surround 
a very small portion of cytoplasm followed by internalization 
of this material in a vacuole (Fig. l.l(b)). A scheme has 
been put forward (Dean, 1978), suggesting that recyling of 
9 
lysosomal membrane components occurs in a manner analogous 
to that described for endocytosis of extracellular proteins 
and plasma membranes (Fig. 1. lb). 
By themselves, these methods of mass engulfment into lyso-
somes cannot account for the variety of individual half-
lives obtained for different proteins in cells (Kay 1978). 
Under steady state conditions, the rate of degradation of 
each cytosolic component should be the same and should be 
solely a function of the rate of internalization. To over-
come this problem, it has been postulated that, for each 
individual protein, the rate-limiting step occurs before 
the internalization (uptake) stage, or that there is some 
selectivity inherent in the uptake step itself, or that each 
protein has a different susceptibility to the initial prot-
eolytic attack once inside the lysosome. For the last 
possibility to be rate-limiting, the proteolysis step would 
have to be slower than the rate of uptake, so that undegraded 
proteins would accumulate inside the lysosomes. If the 
internaiized proteins had different degrees of resistance to 
the acid conditions and the high protease concentrations in 
the lysosomes, then the long-lived proteins would be those 
that were capable of surviving these conditions and possibly 
even of escaping to their native and functionally active 
state in the cytoplasm. Short-lived proteins would be those 
that were more eas~y denatured and proteolysed and so would 
survive a smaller number of passages through the lysosomal 
compartment. Little evidence in support of such a mechanism 
10 
has yet been obtained. 
The restricted localization and predominantly acidic pH 
optima of lysosomal cathepsins, together with the relative 
instability of most intracellular proteins at lowered pH 
values, as well as the conceptual difficulties of allowing 
whole proteins to escape from the lysosomes, are considera-
tions which suggest that, once exposed to the lysosomal 
conditions, virtually all proteins would be rapidly degraded, 
without differentiation. Thus it would seem more probable 
that the site of selectivity that determines the rate-
li miting step for most proteins has to lie outside t he 
lysosomal compartment. 
Lysosomal proteases. It has been known for many years that 
most tissues contain 11 pepsin-like 11 proteolytic activity not 
dependent on thiol activation. The term 11 cathepsin
11 was 
coined for the enzyme responsible, and the first detailed 
study of II cat heps i n II was made by Ans on ( l 9 4 0 ) . I n l 9 6 0 , 
Press et al isolated and characterized cathepsin D fro m 
bovine spleen. Since then numerous lysosomal proteases 
have been identified in various tissues and detailed studies 
of their properties have been reported. 
Cathepsin Dis a stable enzyme synthesized as a single poly-
peptide chain of about 42 000 molecular weight (Knight and 
Barrett, 1976). The pH optimum of cathepsin Dis about 3,5 
and in addition to haemoglobin, native protein substrates 
susceptible to the protease include cartilage proteoglycan 
11 
(Roughley and Barrett, 1977), myosin (Schwartz and Bird, 
1977) and angiotensinogen (Morris and Reid, 1978). More 
recently, Turk and co-workers (1981) have demonstrated the 
existence of cathepsin D precursor, cathepsinogen D, which 
is converted by intramolecular activation to the active 
enzyme and an activation segment-peptide(s) in a way 
similar to pepsinogen activation. 
Cathepsin B, a cysteine protease, has been isolated from 
and estimated in many mammalian species and tissues (Barrett, 
a+b 
1977). Its molecular weight range between 24 000 and 28 000 
and it is most active at degrading synthetic substrates and 
native substrates at pH 5,5 - 6. 
Cathepsin H, initially purified from rat liver ( Kirschke et 
~' 1972) and maximally active at pH 6 - 7, differs from 
o t h e r l y s o s o m a l c y s t e i n e p r o t e i n a s e s i n l.h""-t- U:: 
w t LL 
Cathepsin L, yet another lysosomal cysteine protease, puri-
fied from rat liver, is characterized by its par-
ticularly high activity in degrading short-lived cytosol 
proteins at pH 6 (Kirschke et~' 1980 ) . At pH 3, however, 
the capacity of short-lived cytosol proteins to serve as 
better substrates than long lived proteins was not evident 
(possibly as a result of changes in conformation). The 
specificity of cathepsin Lat neutral pH values is interesting. 
Okitani et .!l_ (1980) have shown that at pH 7 and 7,5, cathep-
sin L seems to act on proteins by cleaving only restricted 
specific peptide bonds; an example is the removal of the 
12 
ca 2+-sensitivity and ATPase activity of myofibrils; at 
lower pH values, an overall degradation of all muscle 
proteins occurred. 
Cathepsin N (Evans and Etherington, 1978), Cathepsin S 
(Turk~~' 1978) and Cathepsin T (Gohda and Pitot, 1981) 
have also been reported to occur in various rat tissue 
extracts. 
Among the lysosomal proteases, cathepsin B, Hand L have 
proteolytic activity at pH values higher than those usually 
found to be optimal for cathepsin D, for example (pH 3-4). 
The major contributor to this activity at pH 6 is cathepsin 
L (Kirschke et~, 1977). Cathepsin L is also the first 
intracellular protease reported in skeletal muscle (since 
chymase is now regarded to be mast-cell derived - see later) 
that degrades actin (Matsukura ~ ~' 1981). Hence, the 
pH range of activity of the lysosomal proteases from acid 
(pH 3,0) to neutral (pH 7) conditions,with varying substrate 
specificities, lends itself to the postulate that intracellular 
protein degradation could well be accomplished solely by 
lysosomal enzymes, whether intracellularly or in some other 
compartment such as the endoplasmic reticulum. Neutral pH 
acting proteases, such as cathepsin L, could also act on the 
cytoplasmic face of the lysosomal membrane, carrying out 
limited proteolysis of susceptible hydrophobic protein sub-
strates. These may then be internalized by micropino-
cytosis and the final hydrolytic events may be carried out 
by other proteases within the lysosomal matrix. 
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Pepstatin is a specific inhibitor of aspartic proteinases 
and as cathepsin Dis the major cellular aspartic proteinase, 
this agent provides an effective means of specifically inhib-
iting this lysosomal enzyme (Barrett, 1980). On the other 
hand, the peptide aldehydes (leupeptin, chymostatin, elastinal, 
anti pain - Umezawa and Aoyagi, 1977) inhibit cysteine as well 
as serine proteinases, although the susceptibilities of the 
various cysteine proteases to these different inhibitors vary 
with the indiv i dual inhibitor tested (Kirschke et al, 1980). 
Desp i te the identification of numerous lysosomal proteases 
with acidic and neutral pH optima, together with the 
specific and non-specific hydrolyzing capacity of cathepsin 
Lat differing pH values, a model for the sole participation 
of the lysosomal system in the degradation of all cellular 
proteins is unlikely to be correct. The varying specifici-
ties of the lysosomal proteases do lend themselves to the 
notion that some limited selectivity in the lysosomal com-
partment may be operative, although extralysosomal events 
such as altered substrate susceptibility, limited proteo-
lysis, energy-dependent cytosolic proteolytic mechanisms 
and membrane attachment (uptake) are equally likely to par-
ticipate at various stages in the overall selective, degrad-
ative process. 
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1.2.3. Non-lysosomal intracellular proteases 
1.2.3.1. Protease activities in skeletal muscle 
Considerable attention has been focussed on proteases with 
pH optima in the neutral and alkaline range, particularly 
as some of these enzymes have appeared to be associated 
with muscle-specific proteins which they can degrade. These 
proteases are found in both the particulate and soluble 
fractions of the cell. Calcium-activated protease (Busch 
~ ~, l 9 7 2 ) re mo v e s Z - l i n e s fr o m my o f i b r i l s , h y d r o l y s e s 
denatured casein, [
3H]acetyl haemoglobin and N-ethyl[
3HJ 
malei mide-labelled a-actinin (Reddy et~' 1975) and is 
eluted from DEAE-cellulose columns by 0,25 M NaCl (Waxman 
and Krebs, 1978). This enzyme is widely distributed in 
other tissues, and in kidney and lung the activity is 2,5 
and 9 times greater than in muscle (Waxman, 1979). The 
ubiquity of its distribution suggest functions other than 
muscle cell protein turnover. A similar calcium-activated 
or dependent-neutral protease has been described in rat skel-
etal muscle (Kohn, 1969), but this protease does not hydro-
lyze haemoglobin and may be a separate enzyme. More recently, 
a calcium-dependent protease has been identified which re-
quires calcium in the µmolar range for activation, a property 
compatible with a physiological role for the protease in 
protein degradation (Dayton et al, 1981). 
Th f f th t t . . ' b . 1 C 
2 + e orm o e pro ease ac 1va~ea y m1cromo ar a concen-
trations appears to be less negatively charged than the form 
requiring millimolar ca
2
+ as the former elutes from a DEAE-
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cellulose column at a lower KCl concentration, and also has 
a lower mobility in non-denaturing polyacrylamide gel elec-
trophoresis, than the latter form (Dayton~~' 1981). It 
is thus possible that the one form of the protease may be 
converted to the other by a reversible process such as phos-
phorylation or an irreversible process such as proteolysis. 
This represents an attractive model for the flexible control 
of activity of this protease, since the interconversion of 
the enzyme would produce activity or inactivity at the low 
free calciu m concentrations normally found inside muscle 
cells. The isolation of an endogenous inhibitor of the 
calc i um-activated protease (Okitani ~ ~, 1976; Waxman 
and Krebs, 1978) provides a possible further co mponent in 
t he control of the activity of the calcium-activated protease, 
although further studies of the mechanism of interconversion 
and precise localization of the protease(s) and inhibitors 
in muscle cells are needed to understand t heir roles in 
intracellular muscle cell proteolysis. 
Alkaline proteases that sediment in the particulate fractions 
of muscle homogenates include the so-called 
11 myofibrillar 11 
protease from rat skeletal muscle (Holmes~~' 1971; Mayer 
..e..:t _g_J, 1974; Dahlman and Reinauer, 1978), and serine prot-
eases that have been found in various preparations of rat 
skeletal muscle (Kat~numa _gJ .£1, 1975; Sanada et al, 1979) 
and rat heart (Murakami and Uchida, 1978). Recent evidence 
(aimed primarily at ridding tissues of mast cells by the 
mast cell degranulator, compound 48/80) have indicated that 
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most or all of this activity resides in mast cells rather 
than in muscle cells (Park et al, 1973; McKee et al, 1979; 
Edmunds and Pennington, 1981). In addition, measurement of 
this activity in isolated heart muscle cells (McKee~~. 
1979) and more recently in striated muscle cells in culture 
(Bird et al, 1981) has confirmed that this activity resides --
in mast cells in un-homogenized tissues. Despite 
this strong evidence for non-muscle cell location of the 
11 myofibrillar 11 protease, earlier reports had indicated that 
this activity correlated with manoeuvres aimed at enhancing 
muscle proteolysis (Mayer~~. 1974; Kat an u ma et al , 197 6) --
suggesting that the mast cell chymase was either a limiting 
factor in the degradative process of muscle cell proteins 
(this was the view maintained by these authors) or that the 
enhanced chymase activity was unrelated and independent of 
the biochemical processes determining enhanced in situ 
proteolysis in these states. Measurements of in situ 
proteolysis of intact isolated skeletal muscles from normal 
and mast cell-degranulated rats, have been reported by Libby 
and Goldberg (1980). Their results suggest that basal 
proteolysis is not limited by chymase activity. McKee et 
~ (1979) have observed similar results in~ vitro experi-
ments with the perfused heart and isolated heart cells. A 
comparison between altered in situ rates of proteolysis in 
skeletal muscles and assayable chymase activities is not yet 
available. 
More recently, high molecular weight proteases have been 
described in liver homogenates (Rose~~. 1979; De Martino 
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and Goldberg, 1979), rabbit skeletal muscles (O kitani ~ £1, 
1981) and in human and rat skeletal muscles (Hardy~ al, 
1981). Although there are several properties in common 
between these macroproteases, the interesting question is 
whether such activities are related to the long-established 
energy requirement of the degradative system. Most inter-
esting and novel observations in relation to the energy 
dependence of protein degradation in reticulocytes have 
been reported by Hershko and co-workers (1979, 1980, 1981) 
where for the first time mechanistic evidence for an ATP-
dependent multi-component pathway for the degradation of 
soluble protein substrates has been presented. The role 
of ubiquitin in such a system has been clearly demonstrated 
(see below) and curiously a macroprotease (which by itself 
is stabilized in the presence of ATP against thermal inacti-
vation) has also been identified. Only one of the above-
mentioned macroproteases bears resemblance to this high 
molecular weight protease in reticulocytes with regard to 
the property of ATP-dependent thermal stabilization, namely 
the liver macroprotease of Rose et al (1979). 
Etlinger et al (1981) have confirmed some of the earlier ob-
servations of Hershko and colleagues of an ATP-dependent 
proteolytic system in reticulocytes and they have further 
shown that this ATP-dependent system decreases with reticulo-
cyte maturation while an ATP-independent system increased. 
Poly-L-lysine was found specifically to inhibit the energy-
requiring system. In addition, crude extracts prepared 
from rabbit back and leg muscles were noted to contain an 
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ATP-dependent and an ATP-independent protease system where 
on ly the former was inhibited by haemin and chromatography 
of this material on DEAE-cellulose revealed ATP-dependent 
co-operativity between the adsorbed and non-adsorbed material. 
Th ese investigators were unable to confirm ATP-dependent 
appearance of substrate-ubiquitin conjugates,and furthermore 
di d not comment on studies comparing this ATP-dependent sys-
tem in muscle extracts from exsanguinated and non-exsanguinated 
exp erimental animals. 
1 • 2 • 3 . 2 • ATP-dependent ubiquitin-dependent proteolysis in 
reticulocytes 
One im portant and until recently unexplained feature of 
pr otein breakdown is that inhibitors of energy production 
reversibly block this process (Goldberg and St John, 1976; 
Old en and Goldberg, 1978). A multi-enzyme, energy-dependent 
pr oteolytic system in reticulocyte extracts, in which ubi-
qui t i n enters into covalent linkage with endogeno us and exo-
genous substrates, has been extensively investigated by 
He r s hk o and co-workers (1979, 1980, 1981). 
Ear li er observations showed that reticulocyte lysates, pre-
pared from ATP-depleted rabbit reticulocytes, contained little 
ATP-independ~nt protease activity against denatured globin 
substrate, while ATP addition resulted in a marked enhance-
ment of globin degradation by crude lysate preparations 
( Ciechanover ~ .!}_, 1978). At the time, the system was 
resolved into two fractions in order of their elution from 
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DEAE-cellulose; fraction I, a 9000 dalton heat-stable poly-
peptide which did not adhere to the DEAE-cellulose, and 
fraction II, the adsorbed protein fraction - neither of 
these fractions by themselves showed the degree of ATP en-
hancement observed, while reconstitution of these fractions 
restored the original ATP-stimulated effect. Fraction II 
was subsequently resolved into two further components by 
ammonium sulphate fractionation, fraction IIA (0-38 % cut) 
a heat-labile (42 °C), high molecular weight protease requir-
ing ATP for stabilization, and fraction IIB (42-75 % cut), 
relatively stable at 42 °C (Hershko ~ .!.}_, 1979). It was 
also shown by ATP tra pping (with hexokinase and glucose) 
that all three components (i.e. fractions I, IIA and IIB) 
required the continued presence of ATP, and no single com-
ponent was an ATP-independent terminal protease or peptidase. 
Following the purification and radio-labelling the heat-
stable fraction 1 (also called ATP-dependent proteolysis 
factor 1 or APF-1 ), it was shown that this polypeptide en-
tered into high molecular weight covalent conjugates with 
endogenous substrates in fraction II (Wilkinson et £1_, 1980), 
and later this observation was extended to similar conjugates 
being formed between APF-1 and other substrates (lysozyme, 
globin or a lactalbumin) for the ATP-dependent proteolytic 
system (Hershko ~ ~. 1980). By use of gel chromatography 
and NaDodS0 4 electrophoresis, at le
ast two enzymatic activi-
ties were demonstrated in relation to the conjugate comp-
lexes formed, the first responsible for the synthesis of a 
chemical bond between APF-1 and the E-NH 2 gro
up of lysine 
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in polypeptides (termed 11 APF-l-protein amide synthetase
11
), 
and a second enzyme ( 11 amidase 11 ) leading to the regeneration 
of APF 1 fr
om APF-1-protein and this regenerated APF-1 was 
subsequently demonstrated to be re-cycled in the formation 
of further high molecular weight conjugates (Hershko ~ ~. 
1 980). 






1 (APF)n - Protein + 
nAPF nATP 
13 
nAPF-X + Amino acids 
APF - protein amide synthetase (acting on E-NH 2 groups) 
Amidase that allows correction when n = 1 or 2 
Peptidases that act strongly on (APF-1) derivatives, n 
when n > 1 or 2 
4. Amidase for APF-1-X; X is lysine or a small peptide. 
Subsequently, APF-1 has been fully characterized (Ciechanover 
a 
et al, 1980) and found to be a heat-stable polypeptide found 
universally in mammalian cells, viz. ubiquitin (Wilkinson 
~ tl, 1980). Ciechanover and co-workers have also shown 
that an SH-enzyme in fraction II carries out the activation 
by ATP of APF-1 by pyrophosphate displacement (Ciechanover 
et tl, 1981). The adenylate is subsequently transferred to 
an acceptor sulphydryl on the enzyme - the nature of such a 
thiol ester bond being confirmed by cleavage of this linkage 
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by hydroxylamine, sodium borohydride as well as salts of 
mercury. Furthermore, this work has been extended to show 
that the active form of ubiquitin has the COOH-terminal 
sequence of Arg-Gly-Gly at residue numbers 74-76, whereas 
74 
the inactive form terminates in Arg , the latter being a 
limited tryptic digestion product of the former dur in g the 
purification procedure. Most recently, Haas and Rose (1981) 
have demonstrated that haemin effectively inhibited overall 
ATP-dependent ubiquitin-dependent proteolysis as well as con-
jugate degradation to exactly the same extent. A mod el was 
thus proposed in which haemin acted as a negative allosteric 
effector in the initial step of a sequential degradative 
pathway by which intact ubiquitin conjugates are f i rst cleaved 
to ubiquitin-associated fragments. 
Ciechanover and co-workers (1982) have purified the ubiquitin-
activating enzyme by "covalent affinity" binding t o ubiquitin-
Sepharose. The purified enzyme has an apparent molecular 
weight of 210000 and appears to be composed of tw o subunits 
of 105000. Subsequent to this, Haas .e...i .a.l (1982) ave shown 
that the ubiquitin-activating enzyme catalyzes the reaction: 
2ATP + 2Ub + ESH 
with the formation of enzyme-bound COOH-terminal ubiquitin 
thiol ester and a COOH-terminal ubiquitin adenylate. These 
observations indicate that ATP hydrolysis is couple d to the 
formation of activated ubiquitin intermediates that have 
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the energy to proceed to conjugate formation in the absence 
of additional ATP. Further investigationsinto the general 
role of ubiquitin have been reported by Matsui~~ (1982) 
where an enzyme termed isopeptidase has been identified, in 
eukaryotic cells, which cleaves A24 stoichiometrically into 
histone H2A and ubiquitin. They propose that the attachment 
of ubiquitin to core histones (H2A and H2B) leads to the re-
pulsion of adjacent chromatin fibres and that this relaxation 
of chromatin fibres, in turn, enables non-histone chromatin 
protein such as regulatory proteins and RNA polymerases to 
bind to accessible genes. 
Research, therefore, in elucidation of the molecular details 
of the energy requirement of proteolysis has led to the iden-
tification of several components in this process in which the 
participation and dependence upon ubiquitin has clearly been 
demonstrated. A schematic model, based on results obtained 
by Hershko and co-workers for reticulocytes, is presented 
(Fig. 1.3). While novel observations have been made, further 
studies with selective inhibitors of the selective steps are 
necessary to elucidate the precise sequential stages in this 
proposed pathway, to discover whether it has general signifi-
cance in the cells of the body other than reticulocytes, and 
to define its overall intracellular roles. 
1.2.4. Endogenous inhibitors of proteases 
With growing interest in intracellular proteinases in recent 
years, there has also been concomitant interest in the possible 
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Fig. 1.3 
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presence of intracellular inhibitory substances. Such 
inhibitory substrances have the potential for masking the 
activity or presence of proteinases in crude muscle homo-
genates, and may also be important regulatory agents in 
protein degradation. 
Noguchi et~ (1972, 1974) reported that an inhibitor was 
present in the supernatants of muscle homogenates. This 
factor inhibited autolysis of muscle tissue in the alkaline 
pH range. The inhibitor had properties similar to those 
of ser um a 1-trypsin inhibito
r. Katunuma and colleagues 
(1977) reported a specific inhibitor to their "group-specific 
protease", isolated from skeletal muscle tissue. This inhi-
bitor appeared to be a peptide with an apparent molecular 
weight of less than 5000 daltons, which existed in the same 
subcellular fraction as the proteinase. An inhibitor (mol. 
weight 8000) in muscle supernatant fractions was isolated 
by Beynon and Kay (1978); the activity of the inhibitor 
decreased when animals were fed protein-free diets or were 
starved. Afting et al (1979) have reported a proteinase --
inhibitor in rat uterine myometrium which has the character-
istics of a glycoprotein and an apparent molecular weight 
of 90000. It inhibited a neutral proteinase from uterus 
that co-purified with the actomyosin complex and which degraded 
myosin. The amount of inhibitor increased 15-fold during 
pregnancy and then decreased to normal levels during post-
partum involution. The authors suggested that the inhibitor 
regulated the action of the neutral proteinase on actomyosin, 
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since actomyosin is rapidly degraded only after parturition. 
Waxman and Krebs (1978) have reported the isolation of two 
proteinase inhibitors from extracts of bovine cardiac muscle 
homogenates; a 270000 dalton inhibitor showed specific acti-
vity towards the calcium-activated proteinase from this tis-
sue, while the second inhibitor (70000 dalton) was a trypsin 
inhibitor. In addition, reports of inhibitors of the lyso-
somal cathepsin Band H have appeared (Lenney ~ ~' 1979), 
and more recently an endogenous thiol protease inhibitor from 
rat liver has also been described (Kominami ~ ~' 1981). 
The identification of protease-specific inhibitors in muscle 
extracts creates the possibility that the activity levels of 
proteases in subceTiular compartments may remain unchanged, 
but that~ situ activities of such enzymes may be regulated 
by modulation of inhibitor activity. Such inhibitor effects 
could vary depending on the presence of active or inactive 
forms of the inhibitor, compartmentation and access control 
between inhibitor and specific protease(s), while differential 
enzyme susceptibility to inhibitors could be a further factor. 
Thus, enzymes could exist in susceptible (soluble) forms or 
insoluble or particle-bound forms. Blood-borne inhibitors 
must also be taken into account, in terms of a possible in-
fluence on intraceTiular degradative events. With regard to 
this possibility, it has already been demonstrated (Stauber 
~ _!}_, 1981) that some a 1 anti-trypsin can be located within 
muscle cells and that its levels may be correlated with 
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states of enhanced proteolysis (see under 
1 Methodological 
considerations'). 
In one system of rapid, physiological proteolysis, the in-
voluting uterus, Afting and his colleagues have postulated 
control of proteolysis to be exerted mainly at the level of 
inhibitor content of the cells rather than by the activity 
of protease (Afting ~ .!.!_, 1979). Further insights into 
these types of interactions will clarify the role of endo-
genous inhibitors in the pathway(s) of protein degradation. 
1.2.5. Pathway Models 
Proteins with large subunits are in general degraded more 
rapidly than those with smaller molecular weight subunits. 
This has been shown by studies utilizing mainly the double-
labelling techniques (Dice~~' 1979; Momany ~ ~' 1976). 
The correlation was not so marked when expressed on the 
basis of multimeric molecular weights of the intact proteins. 
Thus it apears that intracellular multimeric proteins may 
disaggregate as a pre-requisite for degradation, which then 
takes place at the level of the subunits. 
The molecular property of surface charge expressed as iso-
electric point has also been correlated with half-life of 
groups of proteins inside cells. Thus acidic proteins are 
degraded more rapidly than basic ones (Dice and Goldberg, 
1976). Furthermore, it has been proposed that the distri-
bution of hydrophobic amino acid residues between the 
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interior and the surface of each protein could be a deter-
minant of its degradation rate (Ballard, 1977). 
Rapidly turning over proteins appear to have a greater 
general hydrophobicity since they accumulate preferentially 
at aqueous/organic solvent interfaces and bind to hydrophobic 
chromatography resins such as phenyl-sepharose with greater 
affinities than do proteins with long half-lives (Bohley and 
Riemann, 1977). The possibility that selective binding of 
proteins to lysosomal surfaces might lead to their selective 
internalization and degradation has been proposed before 
(Dice and Goldberg, 1976). Selective binding of proteins 
to hydrophobic surfaces (Bohley and Riemann, 1977) and to 
external surfaces of lysosomes and other membranes (Dean, 
a 
1975) has in fact been shown to occur. For example, Bohley 
and associates (1981) found that the hydrophobicity of cyto-
sol proteins from rat liver homogenates (prepared from rats 
fed a protein-free diet) was diminished in comparison with 
the affinity of cytosol proteins from normal or protein-fed 
rats. Such changes in the state of cytosolic substrates may 
play a rate-limiting role in the transfer of these proteins 
to other organelles (e.g. microsomal membranes or membranes 
of lysosomes), for their ultimate degradation to amino acids. 
A further o~ervation links the half-lives of intracellular 
proteins~ vivo to their susceptibility to attack by endo-
peptidases~ vitro (Yamasaki and Ichihara, 1976). Cyto-
plasmic proteins with short half-lives (as measured from 
isotope ratios after double-labelling experiments) are more 
28 
susceptible to digestion at neutral pH by extracellular 
enzymes, such as trypsin and pronase, than their long-lived 
counterparts. 
More recently, Holzer ( 1981) has shown that yeast fructose 
l,6-bisphosphatase undergoes covalent conversion (metabolic 
interconversion) by phosphorylation of a serine-residue and 
this form of the enzyme may show a different susceptibility 
to proteinases. In addition, it has been shown (Bond and 
Offermann, 1981) that disulphides (oxidized glutathione or 
cystine) reversibly inactivatednative rabbit muscle aldolase 
resulting in unstable protein conformations which were very 
extensively degraded by lysosomal and non-lysosomal proteases. 
This suggests that the formation of such protein-glutathione 
mixed disulphides may be the initial step in the degradation 
of proteins where the relative susceptibility of -SH groups 
on soluble proteins to such oxidations may explain the 
heterogeneity of enzyme half-lives. Pace and associates 
(1981), in their studies relating to the stability of globu-
lar proteins, indicate that about 30 % of accessible side 
chains of a typical globular rpotein are nonpolar, while 
over 80 % of the buried side chains are non-polar. Thus, 
dissociation, unfolding or any other conformational change 
will yield a considerably more non-polar molecule which, in 
turn, will increase the affinity of the molecule for lyso-
somal or other membranes, and hence could be an important 
determining factor in the selective degradation of cellular 
proteins. 
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The molecular properties of substrate proteins which may thus 
be important in determi ning degradative rates include molec-
ular weights, iso-electric points, hydrophobic amino acids on 
the surface, phosphorylation, and other covalent modifications 
(e.g. formation of mixed disulphides) and the general conforma-
tional stability of globular proteins. However, substrate 
susceptibility is clearly only one of several steps in the 
degradative process which may be rate-limiting. Other 
stages which may equally be regulatory will be discussed 
below. 
A variety of studies from different laboratories have indi-
cated that mammalian cells contain more than one proteolytic 
pathway that may serve different functions. For example, 
the degradation of long-lived proteins in hepatocytes and 
fibroblasts differs from that of short-lived proteins in its 
sensitivity to decreased temperature, to inhibitors of lyso-
somal function (such as leupeptin, chymostatin or chloroquine) 
and to nutritional step-down conditions (Hopgood et~, 1973; 
Amenta et~, 1976, 1977; Knowles and Ballard, 1976). If 
a single proteolytic pathway were responsible for the degrada-
tion of all intraceTiular proteins their half-lives would be 
expected to change similarly in responseto these experimental 
manipulations. However, serum deprivation of cultured mam-
malian cells seems to promote selectively the breakdown of 
long-lived proteins without affecting the half-lives of 
short-lived cell constituents {Knowles and Ballard, 1976). 
Furthermore, addition of insulin or serum can depress the 
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degradation of long-lived proteins in cells (e.g. hepatocytes) 
without affecting the rapid breakdown of analogue containing 
or normal short-lived proteins; and under conditions of nut-
ritional and hormonal deprivation, when the lysosomal pathway 
is supposed to predominate, autophagic vaculoles are very 
pronounced (Amenta et~' 1977). Together, these~ vivo 
findings suggest that long-lived proteins, which constitute 
the bulk of hepatocyte proteins are catabolized by a lyso-
somal process or that some steps involve the lysosomes. In 
addition, Mortimore and Schworer (1980) have demonstrated a 
rat her strong correlation between overall proteolytic rates, 
the aggregate volumes of lysosomal elements, and measurements 
of degradable intra-lysosomal protein in states of nutritional 
deprivation and enrichment. This is further support for the 
view that intracellular prote i ns, with the exception of some 
rap i dly turning over components, are degraded intralysosomally. 
However, Dean (1980) has demonstrated that pepstatin, the in-
hibitor of lysosomal cathepsin D, used with liposomes as a 
vector, not only inhibited accelerated proteolysis in the per-
fused liver, but a substantial degree of 'basal I proteolysis 
as well. Although the lysosomal participation in protein 
degradation in accelerated proteolysis is well established, 
the case is not the same for 'basal I proteolysis, and there-
fore the existence of partially separate systems has to be 
postulated to explain these observations. In contrast, a 
non-lysosomal, energy-dependent proteolytic system presumably 
catalyses the rapid breakdown of aberrant proteins and various 
a 
normal proteins with short half-lives (Goldberg et~' 1980 ). 
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There is little evidence for the accumulation of part-
ially degraded protein products~ vivo, suggesting that 
once a protein molecule is launched into the breakdown 
system, it is rapidly degraded to amino acids (Kay, 1978). 
Thus the evidence that certain agents have marked effects on 
the turnover of one category of proteins (the long half-life 
proteins) but little or none on other classes of proteins, 
strongly favoursa dual pathway model for intracellular protein 
degradation. However, from the preceding discussion, the 
rate-li mi ting step(s) of selective degradation of cellular 
proteins may be situated at the level of substrate suscep-
tibility (with the various mechanisms that may alter this), 
early selective limited proteo1ysis by cytosolic proteases, 
membrane attachment/uptake (lysosomal or other) or selective 
intralysosomal attack. Furthermore, the isolation of endo-
genous inhibitors (ref. 1.2. 4) of proteases adds further 
complexities to the construction of a satisfactory model. 
The roles of organellar compartmentalization of proteases and 
their inhibitors, variations in the absolute levels of these 
inhibitors and proteases, interconversion of inhibitors/ 
proteases into active or inactive forms and restricted speci-
f i c i t y o f i n h i b i t o rs/ p r o t e a s e s at th e l e v e l o f r a t e - l i mi t i n g 
steps all require careful evaluation. When the activities 
of protease(s) and inhibitor(s) do not correlate with altera-
tions in protein degradation rates~ situ, no firm conclusion 
can be drawn about their participation in the overall degrada-
tive process, since they may not be involved at metabolic 
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control points. However, as the identity of individual 
reactions, precise sites of rate-limiting steps, effects of 
endogenous inhibitors, determinants of substrate suscepti-
bility and the overall control mechanism(s) remain unresolved 
questions, the details of most models for intracellular protein 
degradation at this stage are in the main speculative (Fig. 
1. 4.). 
1.3. THE ENDOCRINE (HORMONAL) REGULATION OF PROTEIN DEGRADA-
TION IN SKELETAL MUSCLE 
The nett balance between protein synthesis and protein degra-
dation determines whether any muscle undergoes growth or 
atrophy (wasting) (Goldberg and St. John, 1976). This bal-
ance varies under a variety of conditions, including accele-
rated growth, starvation, various endocrine disease states 
(e.g. hyperthyroidism, diabetes mellitus, Cushing's Syndrome) 
and increased use or disuse of muscle. Furthermore, as 
muscle protein constitutes an important fuel reserve in the 
body, enhanced proteolysis and the production of amino acids 
during this process, with the subsequent metabolism of the 
glycogenic precursors in the liver and kidney cortex, serve 
metabolic adaptation during periods of increased demand. 
Therefore protein synthesis and degradation in skeletal 
muscles is likely to be under careful regulation, and in 
this context hormonal control forms an important mediator of 
these effects in the various physiological and pathological 
states. Several laboratories have employed .ill vitro tech-
niques to analyse rates of protein degradation and synthesis 
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under carefully controlled conditions using thin rat or mouse 
muscles (e.g. diaphragm, red soleus or pale extensor digi-
toru m longus muscles) (Fulks et al, 197 5 ; Libby and Goldber g , 
1980 ) . Rates of incorporation of [14 c] tyrosine or phenyl-
alanine into the incubated muscle represent protein synthesis, 
after correcting for intracellular specific activity, while 
protein degradation rates are measured by determining the nett 
release of tyrosine from cell protein (for further details re-
gard in g this in vitro methodology - refer (1.4) methodologic 
cons id erations). 
1. 3. l. Influence of in vitro conditions on protein turnover 
in isolated rat muscles 
The in vitro measurement of amino acid release from muscles 
inc ub ated in unsupplemented Krebs-Ringer bicarbonate buffer 
shows that nett protein breakdown occurs under even the best 
cond i tions. The muscle thus resembles skeletal muscle 
during a short fast 2-!!. vivo. To such a system~ vitro, 
various factors have been added to study their influence on 
protein balance (Fulks et~, 1975), and most of our know-
ledge in the area has accrued from such experiments. 
Insulin: In isolated intact muscle, ins ul in inhibits protein 
degradation and simultaneously enhances protein synthesis. 
The inhibition of proteolysis has also been observed in these 
· muscles in the presence or absence of glucose, which also in-
hibits protein degradation. Thus, the ability of insulin to 
reduce muscle proteolysis must be independent of its effect 
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in stimulating glucose uptake by muscle. This response to 
insulin has subsequently been observed in isolated adult 
myocytes and in heart cell cultures (Frelin, 1980). 
Glucose: Fulks and co-workers (1975) have demonstrated that 
glucose addition inhibits protein degradation, while protein 
synthesis is unaffected. The addition of insulin to the 
glucose-containing medium appears additive in improving over-
all protein balance in muscle, although such isolated muscles 
are still in a state of nett breakdown in the presence of 
both these factors. 
Plasma amino acids retard protein breakdown and stimulate 
protein synthesis, although only one amino acid, leucine, 
by itself influences protein turnover in these preparations 
(Goldberg, 1980). Interestingly, during fasting, leucine, 
like fatty acids or ketone bodies, serves as an alternate 
substrate to glucose and is the only amino acid that can 
provide significant energy for muscle (Chang and Goldberg, 
1978). 
Catecholamines: Epinephrine, at physiological concentrations, 
reduces proteolysis in skeletal muscle while norepinephrine 
also causes a nett reduction in degradation, but not to the 
same degree (Garber et~, 1976). This suggests that the 
effect on protein degradation is more a B adrenergic effect 
and this has been confirmed since a B agonist (isoproterenol) 
but not an a-agonist (phenylephrine) can mimic the response 
to epinephrine. 
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Contractile activity of muscle: The addition of glucose, 
insulin as weTI as amino acid, leucine to intact isolated 
muscle did not prevent a nett state of degradation in this 
~ vitro system. As these muscles differ in one further 
respect,with regard to~ vivo muscle in that they do not 
perform work, the effect of repetitive stimulation and pas-
sive tension on protein turnover in vitro has been studied 
(Goldberg et~' 1980). Both these factors retard protein 
breakdown, so that if isolated muscles are provided with the 
above-mentioned factors and maintained under some degree of 
tension, neutral or even positive nitrogen balance~ vitro 
can be observed. 
l .3.2. Influence of various factors on protein turnover 
meas.ured in vitro 
Pituitary and thyroid hormones. The observation that hypo-
physectomy of young animals prevents normal body growth and 
protein accumulation in skeletal muscles is well known 
(Flaim et al, 1978a). - -
b 
Goldberg and co-workers (1980) con-
firmed earlier findings that protein synthesis is reduced 
following the removal of the pituitary, but in addition, 
showed that rates of protein breakdown were also much slower 
in muscles of hypophysectomized rats. The fall in protein 
synthesis was attributed to the lack of growth hormone, 
while the reduction in protein catabolism could not be imme-
diately explained. Treatment of hypophysectomized rats 
with growth hormone did not alter rates of protein degradation, 
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while rates of protein synthesis increased (Goldberg, 1969; 
Goldberg et~' 198Ub). Further studies indicated that defi-
ciency of thyroid hormones was responsible for the decrease 
in protein breakdown following hypophysectomy (Flaim et~. 
1978b). Treatment of these rats with either triiodothyro-
nine (T 3) or thyroxine (T 4 ) increased the rates of protein 
degradation to levels seen in control animals (Goldberg et 
~, 1980b). This stimulation of proteolysis by thyroid hor-
mones was similarly observed in thyroidectomized rats, which 
also had decreased levels of protein degradative rates. 
Treatment of these rats with T3;T 4 also stimulated protein 
synthesis in muscle. 
The same group of investigators also noted that small doses 
of T4;T 3 to hypophysectomized rats stimulated synthesis more 
than breakdown (anabolic), whereas administration of these 
hormones in excessive amounts resulted in enhanced protein 
breakdown and loss of weight (catabolic effect). They thus 
demonstrated that a minimal level of thyroid hormone is essen-
tial for normal growth, while an excess of the same (hyper-
thyroidism) leads to a general loss of weight and severe 
muscle wasting. An intriguing and yet unexplained questi on 
is how this hormone can have different dose-response curves 
in a single tissue for its effects in stimulating protein 
synthesis and degradation. 
Glucocorticoids: It is well known that the over-production 
of adrenal steroids in Cushing 1 s Syndrome leads to marked 
wasting of muscle and loss of strength. Although generally 
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assumed to promote protein breakdown, the effects of gluco-
corticoids on protein turnover in muscle remain controversial. 
Early studies indicated that cortisol stimulated protein 
b 
breakdown (Goldberg, 1969). However, several studies have 
not only failed to confirm glucocorticoid-induced enhanced 
proteolysis but furthermore, their observations indicate a 
reduction in rates of both protein synthesis as well as 
protein degradation,by glucocorticoid administration (Shoji 
and Pennington, 1977; McGrath and Goldspink, 1980). How-
ever, this reduction affected protein synthesis more than 
protein degradation, with a nett increase in protein degra-
dation, although the absolute values of protein degradation 
tended to be lower than controls. Stud i es with adrenal-
ectomized rats have shown that fasting produced little, if 
any, nett increase in proteolysis in muscle, while muscle 
from fasted control rats revealed the well known effects of 
decreased protein synthesis and enhanced degradative rates. 
Administration of glucocorticoids to the fasted, adrenal-
ectomizedrats resulted in increase in proteolytic rates 
similar to the fasted control animals (Goldberg, 1980). 
These experiments demonstrate a clear requirement for gluco-
corticoids for the acceleration of protein breakdown during 
fasting. On the other hand, when fed rats (normal/adrenal-
ectomized) were treated with glucocorticoids no increase in 
muscle protein breakdown was observed, suggesting that some 
additional hormone which is dependent upon nutritional status 
(e.g. insulin) may be important in the response of muscle to 
steroids. 
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An interesting observation by Santidrian et £1 (1981) concerns 
an elevated urinary output of 3 methyl histidine associated 
with cessation of growth in adrenalectomized rats treated sub-
cutaneously with large doses of corticosterone. Intraperi-
toneal administration of the glucocorticoid resulted in much 
less severe retardation of growth and gave no changes in 3-
methyl histidine output. This suggests that the intraperi-
toneal route of administration was accompanied by hepatic 
inactivation of the corticosteroid. 
Starvation: Food intake and food deprivation (starvation ) 
are associated with a rise and fall in insulin levels respec-
tively, the former situations characterized by increased 
protein synthesis and decreased proteolysis, whereas the 
latter by a fall in protein synthesis and a nett release of 
amino acids from muscle. These effects confirm the role of 
insulin in growth and its importance in maintaining posit i ve 
nitrogen balance in muscles (Cahill, 1970; Felig, 1975). 
Disuse/Denervation Atrophy: Disuse and denervation lead to 
marked atrophy of muscle which is mainly due to enhanced 
proteolysis (Goldberg, 1969b; Goldspink, 1976). The dec-
rease in rates of protein degradation obtained when isolated 
muscles are maintained under passive tension lends support 
to the argument by physiotherapists that passive exercise of 
disused muscles retards the degree of atrophy (Goldberg, 1979). 
Du Bois and Almon (1981) have detected increase in the number 
of glucocorticoid receptors in denervated compared with con t ra-
lateral control gastrocnemic muscles, supporting the concl usion 
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that such atrophy could be the result of increased sensiti-
vity of individual muscles to normal levels of glucocorti-
coids. These results demonstrated that the increase in 
glucocorticoid receptor sites preceded atrophy, ruling out 
the possibility of a concentration effect. In addition, 
Du Bois and Almon (1981) have shown similar increases in 
glucocorticoid receptors in muscles undergoing disuse atrophy. 
That denervation and disuse atrophy may be mediated by en-
hanced sensitivity to normal levels of hormones, while inner-
vation may play a role in regulating such responsiveness 
seems an attractive mechanism, although further clarification 
of the biochemical details underlying such a mechanism is 
required. 
Testosterone: It has been known for some time that castration 
of rats is followed by decreased growth rate of all skeletal 
muscles as well as reduced body growth. These levels are res-
tored to normal by testosterone administration, thus confirming 
the important anabolic effect of androgens (Scow, 1952). 
Although the anabolic effects of this hormone are well estab-
lished, little information exists as to its influence on protein 
degradation. The increase in muscle mass which follows tes-
tosterone treatment in castrated animals suggests that in the 
absence of testosterone, protein degradation in muscle is not 
retarded. Dahlmann and co-workers (1980) have studied the 
effects of castration and subsequent administration of testo-
sterone on the activity of an alkaline protease in skeletal 
muscle, they demonstrated a 2-3 fold increase in specific 
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activity of the alkaline protease in the castrated group, com-
pared with controls; normal levels were attained on testo-
sterone treatment. In another report, they have described 
a 50 % increase in alkaline protease activity in EDL muscles 
of rats undergoing endurance training and this exercise-
mediated increase was prevented by the simultaneous adminis-
a 
tration of testosterone (Dahlmann et~' 1981 ). They con-
elude that testosterone has a regulatory effect on the protein 
degradative mechanism - although examination of the method of 
preparation of the muscle extract reveals a high salt buffer 
system, ideal conditions for solubilizing the mast cell 
chymase (Pastan and Almqvist, 1966); hence, the activity 
studied was almost certainly the non-muscle cell entity. Evi-
dence for the role of non-muscle cell proteases in the degra-
dation of muscle cell proteins is not available and therefore 
the significance of such correlations in relation to the 
present knowledge with regard to models for the intracellular 
degradation of muscle-cell derived proteins is not known. 
Mechanism(s) of hormonal control: It is therefore clear from 
the above studies that overall rates of protein degradation 
in muscle, like protein synthesis, are subject to precise 
hormonal control. However, the biochemical details of the 
fine mechanism of this control are at this stage mainly specu-
lative. Investigators in this field have looked at the 
activity levels of muscle proteases in various muscle disease 
states to determine whether a correlation between muscle 
wasting and protease activity could be demonstrated. The 
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report by Dahlmann and .co-workers mentioned above is such 
an example. Subsequently to these studies, Dahlmann et~ 
(1981) have also reported that the increased alkaline protease 
activity in starvation, diabetes, testosterone deficiency, 
glucocorticoid injected rats and muscle dystrophy suggest an 
involvement of the mast cell chymase in these pathological 
states, although they conclude that with mast cell degranula-
tion (which abolishes chymase activity) these muscles still 
undergo increased catabolism indicating that 'other proteases' 
(and not the mast cell chymase) are responsible for the in-
creased degradation. Toyo-Oka (1980) has studied the acti-
vity levels of Cathepsin B, Cathepsin D and calcium activated 
neutral protease in cardiac and skeletal muscles of hyper-
thyroid animals and showed that while all these activities 
were increased in skeletal muscle extracts of the hormone-
treated animals, the activities remained unchanged in cardiac 
muscle extracts. De Martino and Goldberg (1978) reported a 
similar increase in the content of lysosomal enzymes in liver 
and skeletal muscle induced by administered thyroid hormone. 
Studies by Hoh et!} (1977), Sartore et tl (1981) and more 
recently by Chizzonite et al (1982) have indicated that 
addition of thyroid hormone results in isomyosin transforma-
tion in the heart and these data provide a molecular basis for 
the observed effects of thyroid hormone on the heart (i.e. 
hypertrophy, increased myofibre-shortening velocity and sig-
nificant increase in calcium-stimulated myosin ATP-ase acti-
vity). Mayer and Shafrir (1974) measured adaptive changes 
of "rat myofibrillar protease" activities in rats after gluco-
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corticoid administration, alloxan-induced diabetes mellitus, 
aminonucleoside induced nephrotic syndrome, fasting, and 
hypoproteinaemia induced by plasmapheresis. The specific 
activity of the protease wasincreased in all these adaptive 
states, and although this protease at the time of the report 
was thought to be of muscle-cell origin, this entity was almost 
certainly the mast cell chymase. Katanuma and Kominami (1977) 
have suggested a physiological role for the group-specific 
protease for apoproteins of pyridoxine enzymes, which also 
increased in states of starvation and with age. However, 
this entity once more represented mast cell chymase and not 
muscle-cell derived protease activity. 
Therefore, although cell-free biochemical experimentation 
may provide data in support of a physiological role for several 
lysosomal and non-lysosomal protease, in many cases the cel-
lular location of the protease under study has not been veri-
fied, while in other cases the effects of the presence of endo-
genous inhibitors, compartmentalization, activation/inactivatio n 
of proteases, make the definition of the details of such hor-
monally mediated effects complicated. 
As mentioned earlier, the fact that nutritional step-down and 
some hormonal effects appear to be mediated via autophage 
lysosomal pathways, the findings of enhanced activities of 
lysosomal proteases following the~ vivo manipulation of 
hormonal status support these observations. However, con-
sideration of the pathway models for the degradatjon of intra-
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cellular proteins suggest that the rate-limiting steps are 
likely to be at the level of substrate susceptibility, early 
limited proteolytic events or the stage of membrane attachment 
(uptake by lysosomes) and not at the level of lysosomal prot-
ease content, as the latter step would require selective re-
cycling of native cytosolic material after its entry into 
lysosomes - and as such recycling has not been demonstrated 
and is unlikely to return native functional cytosolic proteins 
unaltered, selectivity of degradation at the intra-lysosomal 
stage of protein degradation appears unlikely. Thus at 
present, in terms of the degradative model, the rate-limiting 
event(s) for the hormonal regulation of protein degradation 
appear(s) to have an extra-lysosomal location. Suc h possible 
sites are outlined schematically (Fig. 1.5), where hormonal 
regulating factors may act at various rate-limiting steps of 
the pathway, while other proteases (lysosomal and non-lyso-
so mal) may also participate in this process tho ugh not limiting 
the overall process. 
The importance of hormonal factors in the influence and con-
trol of protein degradation is clear, although the molecular 
mechanism(s) underlying these events are not characterized 
at this stage. Further insight into the knowledge of the 
physiologic pathway(s) of protein degradation ought to shed 




























































































































































































































































































1.4. METHODOLOGIC CONSIDERATIONS 
The technical problems involved in measuring rates of protea-
lysis in muscle are particularly challenging. Three exper1-
mental approaches have generally been used to study intra-
cellular protein degradation. The first has attempted to 
measure degradation rates~ vivo by administration of a pulse 
of a radio-labelled amino acid to serve as a precursor for 
incorporation into protein in the whole animal. The rate of 
release of the label from the polymeric form back into the 
free amino acid pool is then considered to be a measure of 
degradation. Calculation of rates of protein breakdown in 
muscles of intact animals (in vivo) involve a number of ass ump -
tions that are st i ll controversial; such calculations are 
also subject to a number of artifacts, such as those due t o 
re-utilization of radio-isotopically labelled amino acids 
(Goldberg and Dice, 1974; Zak et~. 1977). 
The second experimental approach has been the use of isolate d 
cells or cells in culture. This technique allows easy access 
to control of environmental conditions, e.g. additions of 
hormones, amino acid depletion, lack of vitamins, effects of 
protease-specific inhibitors, energy depletion, etc. - th us 
providing information on the behaviour of the entire degra da -
tive machinery and indicating to what degree inhibitors of 
known proteases affect this process. For example, the dif-
ferent rates of degradation obtained from endogenous but ex tra-
cellular 3H-labelled macrophage proteins and the endogenous 
but intracellular 14 C-labelled proteins, as well as the 
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observation that the breakdown of the 3H-labelled proteinswas 
more strongly inhibited by chloroquine, suggested that differ-
ent mechanisms in different compartments of the cell were res-
ponsible for the degradation of exogenous and endogenous 
proteins (Kay, 1978). 
The urinary excretion rate of 3-methyl histidine has been used 
as an index of muscle-protein degradation~ vivo (Youna ~ ~. 
1972; Long et~. 1977; Ballard g__!_ ~. 1979). This amino 
acid originates from the degradation of actin and some species 
of myosin heavy chains in which it is present after the post-
translational methylation of specific histidine residues 
(Young et~, 1972). Following degradation of myofibrillar 
protein, the methylated histidine is released, does not under-
go re-utilization or metabolism, and is quantitatively elimina-
ted in the urine (Young and Munro, 1980). The use of 3-methy l 
histidine as a measure of muscle protein breakdown rate assumes 
that the bulk of urinary 3-methyl histidine comes from skeletal 
muscle, with only a small proportion being released from other 
organs, notably skin and intestines (a meat-free diet is also 
required). In this regard, measurement of 3-methyl histidine 
turnover in rat skeletal muscle, skin and gastrointestinal 
muscle, indicated that skeletal muscle contributed to only 
25 % of the total urinary excretion (Millward et~. 1980). 
However, Harris (1981) has shown, by recalculating data of 
urinary 3-methyl histidine excretion in rats, that skeletal 
muscle tissue is the major contributor of 3-methyl histidine 
in the urine, a conclusion supported by Santidrian et~ (1981 ) . 
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Thirdly, in order to measure protein degradation under care-
fully controlled conditions, wide use has been made of a 
relatively simple and standardized~ vitro techniques in-
volving the use of thin rat or mouse muscles that can be 
maintained in vitro for several hours in an apparently stable 
physiological state (e.g. the diaphragm, red soleus muscle, 
or pale extensor digitorum longus muscle) (Fulks et al, 1975). 
Overall protein breakdown in such isolated muscles is measured 
by determining the release of tyrosine from tissue protein. 
Nett production of this amino acid must represent a nett 
protein breakdown by the tissue since muscle neither synthe-
sizes nor degrades tyrosine. However, some investigators 
have equated protein breakdown with the release of alanine 
and glutamine from muscle - this is not valid as these amino 
acids are synthesized~ novo in large amounts (Garber et 
~' 1976; Odessey et~' 1974). Since these tissues in 
vitro generally maintain constant intracellular pools of 
tyrosine, the release of tyrosine from muscles reflects the 
nett hydrolysis of tissue protein, that is the rate of tyro-
sine production by protein breakdown minus the rate of tyro-
sine re-incorporation through protein synthesis. To measure 
protein breakdown in isolation, muscles have generally been 
incubated in the presence of cyc1oheximide (0,5 mM) which 
inhibits protein synthesis (Fulks, et~' 1975; Libby and 
Goldberg, 1980). Although cycloheximide may reduce absolute 
rates of degradation, the regulatory effects of various physio-
logical factors on proteolysis can still be measured (Fulks 
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~ ~' 1975). Where this has been studied, the rates of 
protein breakdown in intact animals have correlated well 
with the rates of this process in isolated muscles, e.g. in 
hypophysectomized animals treated with replacement doses of 
thyroid hormone, the rate of muscle protein breakdown in-
creases as measured both~ vivo, using a pulse chase tech-
nique, or in the isolated muscles~ vitro (De Martino et~' 
1977). 
Further useful contributions from cell-free studies in vitro 
include cell-free experimentation which has led to the identi-
fication of several lysosomal and non-lysosomal proteases as 
well as endogenous inhibitors. As muscle tissues contain 
cells of many types (i.e. myocytes, fibroblasts, mast cells, 
endothelial cells, adipocytes), mixing of subcellular frac-
tions from these differing cell types cannot be avoided. One 
such non-muscle cell which populates muscle tissues and con-
tains vesicles packed with"alkali" and"acicf' hydrolases, is the 
mast cell (Pepys and Edwards, 1979). This fact has recently 
led to investigators ridding muscles and other tissues of 
these cells by mast cell degranulation, prior to evaluating 
~ vitro muscle protein degradation in intact muscle (Libby 
and Goldberg, 1980) or ceTI-free protease activities in muscle 
homogenates (McKee et~' 1979; Edmunds and Pennington, 1981). 
In addition, it should be borne in mind that intravascular 
components may also provide tissue homogenates to some extent 
with their accompanying proteinases, e.g. serine proteinase 
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of neutrophil granulocytes (Barrett, 1977) as well as plasma 
proteinase inhibitors such as a 2 macroglobulin, a 1 protease 
inhibitor and a 1 chymotrypsin (Koj and Kurdowska, 1981). 
Although after having stated this, it ought to be mentioned 
that Stauber~~ (1981) have shown by immunohistochemical 
techniques that the protease inhibitors a 1 antitrypsin and 
a 1 inhibitor 3 are located within muscle cells in normal rats, 
and this intracellular pool decreases in states of enhanced 
proteolysis such .as experimental diabetes mellitus - providing 
a model whereby extracellular protease inhibitors modulate 
intracellular degradative events (e.g. autophagy), and the 
constant supply of inhibitor (possibly by endocytosis) could 
be retarded under nutritional step-down and other physiologic 
or pathologic states . 
Findings with cell-free preparations cannot prove the physio-
logic function of a protease or inhibitor.:!....!!. vivo, as differ-
ences between enzyme behaviour in intact cells and in cell-
free preparations may result from: release of endogenous 
inhibitors, lack of appropriate in vitro conditions, cellular 
or subcellular compartmentation of the enzyme. Nevertheless, 
Hershko and co-investigators have characterized the above-
described multicomponent ATP-dependent proteolytic pathway 
in cell-free extracts which, for the first time, offers a 
mechanistic explanation for the previously well-known energy 
requirement of protein degradation. Such observations of 
the behaviour of cell-free components.:!....!!. vitro, which are in 
accord with.:!....!!. vivo properties, argue strongly for the use of 
51 
such isolation and subsequent reconstitution studies of 
various subcellular components as a vital tool towards a 
total understanding of the overall degradative process. 
Furthermore, the observations of the effects of endogenous 
and exogenous inhibitors on the activities of purified 
proteases have been extended to a study of these inhibitor 
effects on intact isolated muscles (Libby and Goldberg, 1980 ) 
as well as on cells in culture (Dean, 1980), with a view of 
examining the roles of these proteases in.:!..!!. situ and in vivo 
degradation and an ultimate aim of understanding the path-
way(s) of protein degradation and its therapeutic manipulat ion 
in various muscle disease states. 
Degradation studies with intact muscle tissue, isolated musc l e 
cells and muscle ceTis in culture provide information about t he 
in situ, behaviour of the proteolytic machinery as a functio n-
ing unit. Thus, manipulation of conditions in vivo or in 
vitro which alter the flux of the entire system would be expec-
ted to be acting primarily (but not exclusively) at the site ( s ) 
of the rate-limiting step(s) for the overall process(es). 
However, since precise biochemical details about the indivi d a l 
processes and steps in the degradative pathway are not availa :)l e 
at present, caution must be exercised in the interpretation of 
such studies. Cell-free studies, although associated with 
certain limitations (as described above), provide the means 
towards the identification of subcellular constituents and 
participitants in protein degradat 'ion process(es) (i.e. sub-
strates (state, availability and susceptibility), proteases; 
inhibitors; cofactors), and therefore, correlations between 
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assayable levels of proteases (or inhibitors) with whole 
organ proteolytic rates in states of altered proteolysis may 
provide evidence that such entities operate at flux-genera-
ting steps (FGS) in the metabolic process(es) of protein deg-
radation (Fig. 1.6). The corollary to this is that cellular 
components that show levels of assayable activities which do 
not follow the overall direction of the protein breakdown 
process~ situ, while not being candidates for consideration 
as rate-generating components, could very well be partici-
pants in the degradative pathway at non-regulatory steps 
(non-FGS), especially if their location is demonstrated to 
be within muscle cells (Fig. 1.6). 
These flux-generating proteolytic events could mechanisti-
cally be mediated via one of several possibilities: absolute 
changes in protease levels; alterations in inhibitor content 
(interconversion from active to inactive forms or vice versa); 
alternatively, pinocytosis of extracellular plasma inhibitors 
such as a1 antitrypsin which may then influence intracellular 
processes; changes in intracellular milieu (e.g. ionic 
strength, pH) which may suit a specific inhibitor, protease 
or cofactor; or alterations in substrate susceptibility to 
a particular protease. In such a scheme (Fig. 1.6), the 
rate-limiting step may be controlled by regulatory factors 
(e.g. hormones or inhibitors), while other non-limiting com-
ponents carry out their relevant functions in the face of 
no (or even paradoxical) changes in their assayable activities. 
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Fig. 1.6 




overall flux= x or <<x (+ inhibitor) 
* 
Flux generating step (FGS) 
amino 
acids 
in situ flux rate= x (or <<x ( + inhibitor) ) 
in vitro activity: x (or <<x ( + inhibitor)) 
* Other steps (non-FGS) 
in situ flux rate= x (or <<x ( + inhibitor)) 
in vitro activity= >>x (or >x or x (+ inhibitor)) 
r 
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Thus, whereas experiments carried out in vivo provide data 
on rates of degradation of individual proteins and altera-
tions in response to perturbation of some sort, the molecular 
mechanisms, properties of intracellular proteases, substrate 
susceptibility and effects of endogenous inhibitors remain 
uncharacterized in such an experimental design. In contrast, 
adoption of the approach utilizing systems~ vitro provide 
the molecular details of individual proteases, endogenous 
inhibitors, and other subcellular participitants in degrada-
tion and possibly even their regulation, and although one 
may argue that this may not directly represent the functions 
of these entities~ vivo, by combining the information 
gained by the different experimental strategies, investiga-
tors are arriving closer at a composite picture of the process 
of intracellular protein degradation. 
1.5. OBJECTIVES OF THIS STUDY 
Investigations into muscle protein degradation, more specifi-
cally in relation to rat skeletal muscle, have provided more 
and more information pointing to possible roles played by 
intracellular proteases and endogenous inhibitors in intra-
cellular proteolysis. In addition, regulation by hormones 
appears to be complex, while the energy requirement of the 
overall process of protein degradation to the level of amino 
acids, requires an explanation. 
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Particularly interesting questions that arise out of these 
considerations include: Can the components of intracellular 
pathways of protein degradation be reconstituted by the 
classical biochemical approach of resolving the complex 
system by separation procedures, analysing their individual 
activity and assessing how they interact upon reconstitution? 
Is there a specific myofibril-associated protease in muscle 
cells? Does the activity of the mast cell-derived enzyme 
chymase alter when in situ proteolytic rates in skeletal 
muscles alter? Does the state of substrates or enzymes 
affect their interactions with endogenous inhibitors? Can 
the effects of various hormonal or other manipulations on the 
overall catabolic process in isolated skeletal muscles be 
correlated with changes in the assayable levels of specific, 
possibly rate-limiting enzymes or inhibitor levels? Can the 
exciting observations of a multi-component ATP-dependent 
proteolytic system in reticulocytes be extended to skeletal 
muscles, indicating a general role for such a system in 
protein degradation? 
Attempts to answer these questions formed the basis of the 
work reported in this thesis. The means employed included 
cell-free and intact tissue studies of skeletal muscles 
derived from laboratory rats. 
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CHAPTER 2 
THE PROPERTIES AND SIGNIFICANCE OF THE MYO-
FIBRIL-ASSOCIATED PROTEINASE IN RAT SKELETAL 
MUSCLE HOMOGENATES 
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2. 1. INTRODUCTION 
There has recently been considerable disillusionment amongst 
workers in the field of protein degradation, with the most 
active protease whose activity can be detected at mildly 
alkaline pH in skeletal muscle homogenates (Noguchi and 
Kandatsu, 1970; Yasogawa ~ .!l_, 1978; Koszalka and Miller, 
1960; Reinauer and Dahlmar, 1979). This arises from the 
fact that there is convincing evidence that the "myofibrillar 
alkaline protease" has its origin in the mast cells which 
populate rat skeletal, heart and smooth muscle tissue in small 
but significant numbers (Woodbury~ .!l_, 1978; McKee et.!}_, 
1979; Libby and Goldberg, 1980). Accordingly, there is now 
more or less general agreement that the chymostatin-sensitive 
serine protease which associates with the particulate fraction 
of muscle homogenates and which destroys a variety of protein 
s u b s t r a t e s , i n c l u d i n g t h e h e a v y ~ h a i n s o f my o s i n , i s II c h y m a s e " 
present in the granules of the mast cells and liberated during 
homogenization because of the fragility of the particles 
(Edmunds and Pennington, 1981; Reinauer and Dahlmann, 1979; 
McKee et .!l_, 1979). 
At the present time, the questions which remain are whether 
there exists a true muscle-cell derived myofibrillar protease, 
and why the mast cell protease adheres to myofibrils with such 
tenacity that its purification free of myofibrillar proteins 
is a difficult problem when the starting material is washed 
myofibrils (Bosch, 1981). In addition, the stujies of Mayer 
~ .!l_ (1974) have suggested that the chymase activity of 
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skeletal muscles in starved, diabetic and cortisol-treated 
rats varies in a manner consistent with the enzyme's involve-
ment in rate-limiting steps in protein degradation. No 
quantitative studies on mast cells in such rat tissues are 
currently available. 
At a broader level, the more challenging question that 
remains unanswered is the reconstitution and resulting charac-
terization of the step-wise pathway by which selective degra-
dation of susceptible proteins, to the level of amino acids, 
occurs in living muscle cells. Despite the isolation and 
detailed characterization of various proteases in muscle 
homogenates (see Chapter 1), there is as yet no well-supported 
model for proteolysis pathways in which specific roles can be 
assigned to any or all of the various proteases and their 
' 
endogenous inhibitors. It is particularly in relation to 
the latter proteins that there is a shortage of ideas as to 
how the balance between proteases and inhibitors is achieved 
in the context of highly complex intracellular structural 
organization in which some proteins are soluble and others 
membranous or sequestered in cellular compartments. 
Rat skeletal muscle homogenates have accordingly been inves-
tigated by the use of differential centrifugation to prepare 
subcellular fractions. Protease activities present in the 
fractions, as well as enzyme-substrate and enzyme-substrate-
inhibitor interactions, were examined in single and in recon-
stituted fractions, in an attempt to clarify the contribution 
of different subcellular compartments to the overall protea-
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lytic process, and to examine the possible ways in which 
inhibitors operate. The presence of a myofibril-associated 
protease (chymase), active at pH 7,4 and above, has been 
confirmed in such preparations. An interesting difference 
in the response of filamentous and soluble 1 chymase 1 to 
inhibitors present in cytosol fractions has been observed. 
This may provide a model for the differential control of 
cellular proteinases by inhibitors whose effectiveness can be 
modulated by variable supramolecular structure. 
2.2. MATERIALS AND METHODS 
2.2. 1. Preparation of rats 
Long-Evans hooded rats of both sexes (100 or 200 gram body 
mass, as specified in the text and legends) were injected 
intraperitoneally with an anaesthetic dose of pentobarbitone 
sodium and sacrificed by decapitation. The rats were main-
tained, before experimentation, on standard laboratory chow. 
2.2.2. Subcellular fractions from rat diaphragm 
Diaphragms were carefully dissected out, freed of fat and 
connective tissue and cut into fine pieces. These were homo-
genized with an Ultraturrax motor-driven homogenizer (Janke 
and Kunkel, FRG), using two 30-second bursts at medium speed, 
with cooling. Five millilitres of Buffer A (i.e. 25 mM tris-
HCl, 0, 1 M KCl, 2 mM MgCl 2, 2 mM sodium pyrophosphate, 2 mM 
EDTA, and 1 mM dithiothreitol {OTT) pH 7,4) were used per 
gram of tissue. The homogenate was centrifuged at 800 g 
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for 15 minutes; the supernatant was saved (see below) and 
the pelleted material was taken up (5 ml per gram original 
material) in Buffer B (i.e. Buffer A minus pyrophosphate), 
before being resuspended and washed by re-centrifugation. 
The washed pellet was now treated with Buffer B, to which 
triton-X 100 was added to a final concentration of 1%. 
After centrifugation as before, three further washes in 
triton-X 100-free buffer were performed (a modification of 
a procedure by Etlinger et~ (1976)) and the purified myo-
fibrils (MF), which contained no other elements on light 
microscopic examination, were taken up in 0,6 M KCl. 
The supernatant from the first centrifugation step described 
above (apart from samples retained for assays), was centri-
fuged in a Beckman J-21 refrigerated centrifuge at 20 000 g 
for 15 minutes, to obtain a mitochondrial/lysosomal pellet 
{ML) (taken up in 5 ml of Buffer B) and a supernatant frac-
tion; the bulk of the latter was recentrifuged at 100 000 g 
for 60 minutes. The microsomal pellet {SR/SL) thus obtained 
was also resuspended as described above, and the soluble frac-
tion was termed the cytosol fraction. 
carried out at 0-4°C. 
All procedures were 
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2.2.3. Protease Activities 
2.2.3. l. Determination of activities in the various sub-
cellular fractions and reconstitution studies at 
pH 7,4 
The subcellular fractions thus obtained were incubated, indi-
vidually at first, for 3 hat 37°C, in a buffer containing 
25 mM tris-HCl, 0. l M KCl (or 0.6 M KCl where specified), 
2 mM EGTA, l mM OTT, 2 mM MgC1 2 (all at pH 7,4), in the 
absence and presence of added azocasein (2 mg). The incuba-
tions were terminated by addition of trichloroacetic acid 
(TCA, 5% final concentration). Aliquots of the TCA-soluble 
supernatants were assayed fluorimetrically for their content 
of free tyrosine or tyrosine peptides, according to the 
method of Waalkes and Udenfriend (1957). Protease activity 
was expressed as nmoles tyrosine/mg protein (type specified)/ 
3 h. Thus 'MF protease activity' was expressed as nmoles 
tyrosine/mg MF protein/3 h. 
In addition to the measurement of ind i vidual protease activi-
ties in the various subcellular fractions (with either endo-
genous (autolysis) or exogenous substrates), the fractions 
were also incubated in various combinations to determine 
whether complementation between them could be established 
on reconstitution. Appropriate zero-time controls were used 
throughout. Protein was measured by the modified method of 
Lowry!!~ (1951) with bovine serum albumin as standard. 
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The TCA-precipitable myofibrillar proteins were subjected to 
SDS-polyacrylamide gel electrophoresis (in a 10% polyacryl-
amide slab gel) (Porzio and Pearson, 1977), to detect higher 
molecular weight degradation products of individual myofib-
rillar proteins. 
2.2.3.2. Activities c,f 11 myofibril-associated protease 11 and 
calcium-activated protease in various muscle fibre 
types 
Myofibrillar (MF) and post-mitochondrial lysoso mal supernatant 
(P MLS) fractions were prepared from various rat muscles (some 
containing predominantly the fast-twitch, white muscle fibres 
and others predominantly slow-twitch red fibres). 
11 My of i b r i 1 - as soc i ate d protease 11 ( MF - protease ) act i vi ti es were 
measured in the MF fractions at pH 7,4 and 37°c for 3 h {high 
salt - 0,6 M KCl) in the buffer conditions descri'bed in 
2.2.3.1. above. MF-protease activity was measured by deter-
mination of solubilized tyrosine or tyrosine peptides and 
expressed also as in 2.2.3. 1. above. 
Calcium-activated protease (CAP) activities in the PMLS frac-
tions were measured as described by (Pennington, 1977), after re-
moval of 11 CAP inhibitor 11 by acid pre-treatment (pH 5). 
The various muscles studied in this manner included diaphragm 
(mixed red and white muscle fibre type); soleus (predominantly 
red); extensor digitorum longus {white); psoas (white), 
gluteus medius (white) and cardiac ventricular muscle (Millward 
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et~' 1978). 
Activities were expressed as nmoles tyrosine/mg protein/3 h. 
2.2.4. Partial purification of protease 
A triton-washed myofibrillar fraction was solub i lized in 0.6 M 
KCl containing 25 mM tris-HCl, 1 mM OTT and 1 mM ATP (pH 7.4). 
The soluble material (2 ml) was chromatographed on a Sepharose 
6B column (0.9 x 60 cm) and fractions of 1 ml were assayed for 
protease activity in the presence of added azocasein. The 
fractions containing the protease were pooled and assayed with 
azocasein or cytosol (same protein concentration), at both 
low and high ionic strength (0. 15 and 0.6 M KCl, respectively). 
In addition, the protease-containing fraction was dialysed for 
12 h against a buffer at 0. 15 M, centrifuged at 20 000 g for 
20 minutes, and the resultant supernatant and pellet both re-
assayed to determine the extent to which the protease activity 
was sedimentable at low ionic strength in the absence of the 
bulk of myofibrillar proteins (viz. actomyosin). 
2.2.5. Skeletal muscle cells 
The established myoblast cell line LB was originally isolated 
from rat skeletal muscle (Richter and Yaffe, 1970). Cells 
were grown at 37°c in a humidified incubator with 5% CO 2 in 
air. After myoblast proliferation to confluence in the stock 
flask, the cells were dissociated with trypsin-EDTA solution 
and seeded at 10 5 cells per 35 mm petri-dish containing 2 ml 
of growth medium. Once confluent, the cells progressively 
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fused to form large multinucleate syncytia (myotubes) which 
synthesized muscle-specific proteins and contracted spontan-
eously after 7-8 days' growth. Cells were -used between 
fourth and tenth passage in culture, and all experiments were 
initiated on dishes showing approximately 80 % of nuclei in 
myotubes, i.e. 80 % fusion (7-8 days' growth). Cell numbers 
and percentage fusion were determined by counting nuclei in 
cultures fixed in methanol and stained with 0.25 % May Grunwald 
for 10 minutes, followed by 10 % Giemsa for 20 minutes. Skele-
tal muscle cells were harvested from the dish by scraping into 
Buffer A (see above) with a rubber policeman. The cell 
samples were then homogenized and the MF fraction washed and 
prepared as described above. The washed MF pellet was sus-
pended in Buffer B (lacking sodium pyrophosphate) and this 
material was assayed for protease activity, with and without 
casein, at low and high salt conditions as described above. 
Similarly, SDS-polyacrylamide gel electrophoretic analysis of 
the MF fraction before and after incubations was performed to 
determine the major protein constituents of this MF fraction 
from skeletal muscle cells and in addition to detect higher 
molecular weight degradation products. 
2.2.6. Mast cell degranulation 
Degranulation of mast cells was induced according to the 
method of Pastan and Almqvist (1966) and Riley (1959). Rats 
weighing about 200 grams received bi-daily intraperitoneal 
injections of compound 48/80 (Sigma Chemical Co.), according 
to the following protocol: Day 1 - 100 µg/100 gm; Day 2 -
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20 0 µg/100 gm; Day 3 - 300 lJg/100 gm; Day 4 - 400 lJg/100 gm; 
Day 5 - 500 lJg/100 gm. The rats were sacrificed on Day 6, 
and tne diaphragms and selected leg muscles were dissected 
out for fractionation by differential centrifugation, for 
incubation as described above and for histological studies. 
2.2.7. Preparation of radiolabelled substrates 
14 · [ C methyl]globin was prepared by labelling bovine haemoglobin 
according to the method of Price and Means (1971), followed 
by haem extraction as described by Schapira ~ ~ (1968). 
14 c- N-ethylmaleimide-labelled myofibrillar proteins (5 x 10 5 
dp m/ mg) were prepared using myofibrils derived from skeletal 
muscles freed of mast cells by prior treatment with compound 
48/80 (see above). Triton-washed myofibrils were obtained 
as described under 'Subcellular fractions from rat diaphragm', 
solubilized in 0,6 M KCl, 50 mM Tris-HCl, pH 7,4 (lacking OTT) 
and labelled with 14 c-N-ethylmaleimide ( 14 c-NEM) (10 mCi/mmol) 
generally as described by Gerard and Schneider (1979): 8 lJCi 
of 14 C-NEM was added to 5 mg of myofibrillar protein to give 
a fi nal NEM concentration of l mM. After incubation for 30 
minutes in the high-salt buffer system, five volumes of ice-
cold distilled water were added and the myofibrils washed three 
times by repeated centrifugation in this manner. Thereafter 
th e my o f i b r i l s we re s u s p e n de d . i n 5 0 m M T r i s - H C l , 0 , l M KC l , 
2 mM MgCl 2, l mM OTT and dialysed in the cold against this 
buffer before use. 
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2.2.8. Protease assays with labelled protein substrates 
Each assay contained 50 mM Tris HCl, 0,6 M KCl, 2 mM EGTA, 
l mM OTT, 2 mM MgC1 2 (all at pH 7,4), together with l mg MF 
fraction and radioactive substrate (l,5 x 10 4 dpm in the 
case of [14 c methyl]-globin or 8 x 10 3 dpm of 14 c NEM-
my o f i b r i l s ) , i n a f i n a 1 v o 1 u me o f 2 5 0 µ 1 . Incubations were 
p e r f o r me d a t 3 7 ° C for 6 0 m i n , a ft e r w h i ch 2 0 0 µ 1 1 0 % i c e - c o l d 
trichloroacetic acid (TCA) containing 5 mg/ml carrier bovine 
serum albumin was added to each to stop the reactions. 
Aliquots (200 µl) of the supernatant fractions were mixed 
with 5 ml Instagel (Packard Instrument Co., Oowner 1 s Grove, 
Illinois, USA) and counted in a Beckman LS 9000 Liquid 
Scintillation Counter. Protease activity was expressed as 
dpm released in acid-soluble form per hour, after subtrac-
tion of values for reactions not containing added enzyme. 
2.2.9. Materials 
Oithiothreitol (OTT), EGTA, Compound 48/80 and L-triiodo-
thyronine were obtained from Sigma Chemical Co. [ 14 CJ 
Formaldehyde (16.7 mCi/mmol) and [ 14 cJN-ethylmaleimide 
(10 mCi/mmol) were obtained from Amersham, England. Chymo 
statin, leupeptin and pepstatin were purchased from the 
Peptide Institute, Protein Research Foundation, Japan. All 
other chemicals used were of Analytical Reagent grade. 
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2.3. RESULTS 
Various subcellular fractions, derived from rat diaphragms, 
were incubated either singly (autolysis) or in the presence 
of added azocasein, in order to assess their respective 
protease activities. Only the myofibrillar fraction (MF) 
released significant amounts of tyrosine in the presence and 
absence of added azocasein, under conditions of ionic strength = 
0.150, i.e. in four separate experiments, one milligram of 
MF released 11, 12, 10 and 11.5 nmoles of tyrosine per 3 h, 
while with added azocasein (2 milligrams), these rates were 
increased to 26, 28, 25 and 30 nmoles tyrosine/3 h, respec-
tively. Thus the MF contained both enzyme (protease(s)) 
and susceptible substrate(s). Triton washing and repeated 
reprecipitations from high salt solution of MF caused no fall 
in the specific activity, suggesting either that the protease 
had solubility properties very similar to those of actomyosin 
or that the enzyme was associated tightly with these contrac-
tile proteins at low ionic strength, within the native myo-
f i b r i 11 a r f o rm o r i n II n a t u r a 1 a c t o my o s i n " ( f i 1 am e n t s ) . 
Comple mentation tests were next carried out on the subcellular 
fractions from rat diaphragms. In all combinations between 
MF and cytosol-containing fractions, an enhancement of proteo-
lysis beyond the expected additive effects was observed (Table 
2 • 1 ) • 
This complementation suggested that there was either (a) an 
activator of the "MF protease" in the soluble fraction, or 
(b) that a protease in the cytosol acted well on MF proteins, 
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TABLE 2.1 
COMPLEMENTATION IN PROTEOLYSIS BETWEEN MYOFIBRILLAR 
AND CYTOSOLIC FRACTIONS 
Aliquots of MF fraction (each containing 1 mg protein) were 
incubated independently and in the presence of constant amounts 
(in mg protein) of the various subcellular fractions - the 
assays and expression of protease activity were as outlined 
in Methods. The same results were obtained in three separ-
ate experiments. 
MF 
Post MF supernatant 
MF+ Post MF supernatant 
Post ML supernatant 




















as substrates, or (c) that the "MF protease" acted parti-
cularly well on added soluble substrates available in the 
cy to sol . 
Possibility (b) was rendered uniikely by the absence of azo-
caseinase activity in the cytosol (Table 2.2). The other 
two possibilities were accordingly further investigated. 
When an amount of azocasein, equal in protein concentration 
to that added as cytosolic protein in the complementation 
assay, was incubated with MF, the release of tyrosine was 
the same in both instances (Table 2.3). In the same kind 
of comparison, or when standard aliquots of the two were 
added together, the tyrosine release was again the same in 
these mixtures (Table 2.3). This indicates that the more-
than-additive effect of combining MF and cytosol was due to 
p o s s i b i 1 i ty ( c ) a b o v e , i . e . t h at th e i n s o l u b l e my o f i b r i l -
associated protease was capable of ~cting not only on its 
own particulate co-proteins, but also on soluble added sub-
strates, viz. azocasei n or cytosol. 
2.3. l. Incubations at high ionic stre ngth 
There was a marked (4 5-fold) increase in the rates of 
tyrosine release when incubations were conducted in a 
buffer containing 0.6 M KCl rather than 0.1 M KCl (Table 
2.3). The complementation observed at low ionic strength 
between MF and cytosol fractions was not evident at the high 
salt concentration; instead, there was much less proteolysis 
when the fractions were combined than when their individual 
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TABLE 2.2 
PROTEASE ACTIVITIES IN SUBCELLULAR FRACTIONS OF RAT MUSCLE: 
ADDED AZOCASEIN 
Constant amounts (i.e. 1 mg protein) of the various subcel-
lular fractions were incubated in the presence of 2 mg azo-
casein. Protease activities were measured at low ionic 
strength, as described in Methods. 
AnMOLES TYROSINE/3 h 
MF+ azocasein 
PMLS + azocasein 
ML+ azocasein 
SR/SL+ azocasein 








EFFECTS OF AZOCASEIN AND CYTOSOL ADDITION ON PROTEASE 
ACTIVITIES IN MYOFIBRILS AT LOW AND HIGH IONIC STRENGTH 
One milligram (protein) of MF fraction was incubated in-
dependently and with azocasein and/or cytosol in the various 
indicated amounts (at low and high ionic strength), protease 
activity being measured and expressed as described in Methods. 
PROTEOLYSIS (nmoles tyrosi ne/mg/3 h) 
Low ionic strength High ion ic strength 
MF 12 56 
MF+ Cytosol (2 mg) 26 10 
MF+ Cytosol (3 mg) 27,5 10 
MF+ Cytosol (5 mg ) 28 9,5 
MF+ Azocasein (2 mg) 25 58 
MF+ Azocasein (3 mg) 29 59 
MF+ Azocasein (5 mg) 28 59 
MF+ Cytosol (1 mg)+ 26 20 
Azocasein (1 mg) 
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activities were summed. Azocasein in the same concentration 
as cytosol protein produced a different result, in that the 
pattern of low salt complementation was reproduced; albeit 
to a less marked degree. Thus the cytosol contained an 
inh bitor not present in the azocasein solution. 
Additions of 1% Triton X-100 or 1% sodium dodecyl sulphate to 
cytosol-containing incubations fa~ed to remove the comple-
mentation effect with MF at low ionic strengths, suggesting 
that the inhibitor(s) was not membrane-associated. Further-
more, dialysis of the cytosol fractions (using dialysis 
t ~bing with a 12 000 molecular weight exclusion limit) 
failed to remove the inhibitor(s) revealed by incubations 
of MF with cytosol at high ionic strengths. 
2.3.2. Time course 
Rates of tyrosine released were linear with time over three 
hours in the MF fractions, at both low and high ionic 
strengths (Fig. 2.1). 
2.3.3. Dose-response curve for myofibrils 
The pattern of tyrosine released with increasing concentra-
tions of MF fractions, incubated at low and high ionic 
strengths, was linear in both instances, although the acti-
vity at high ionic strength remained greater than that at 































MEASUREMENT OF PROTEASE ACTIVITIES IN MYOFIBRILLAR FRACTIONS 





Aliquots of MF protein (each containing 1 mg protein) were 
incubated at intervals up to 3 h, at low (o) and high (•) 
ionic strengths. Protease activities were measured as 
























EFFECTS OF INCREASING AMOUNTS OF MYOFIBRILLAR FRACTIONS 
ON PROTEASE ACTIVITY AT LOW AND HIGH IONIC STRENGTHS 
0,5 1,0 1,5 2,0 
mg mF protein 
Increasing amounts (protein) of MF fractions were 
incubated at low (o - o) and high ionic strengths 
(• - •). Protease activities were measured after 
3 h, as described in Methods. 
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2.3.4. Azocasein concentrations 
The addition of increasing amounts of azocasein to incuba-
tions containing MF and a constant concentration, at low 
ionic strength, revealed a gradual increase in the amount 
of tyrosine released until a plateau was reached, suggesting 
substrate saturation (Fig.2.3). This plateau value of tyro-
sine released was considerably greater than that achieved 
by MF alone at low ionic strengths, accounting for the 
similar degree of complementation observed when cytosol 
protein was added to MF. Under these conditions (see Fig. 
2. 3) , the p 1 ate au act i vi t y of the 1 ow i on i c strength system 
still fell short of the activity observed with MF alone at 
hig h ionic strengths, indicating that the filamentous form 
of the myofibrils was associated with diminished accessi-
bility of the protease to susceptible protein substrates. 
The level of tyrosine released from MF (0 azocasein) at 
high ionic strength was five-fold greater than that at low 
ionic strength and the addition of azocasein resulted in a 
small increment which rapidly reached a plateau as the azo-
casein was increased. This suggested that, at high ionic 
strength, more of the protease was available to act upon 
associated myofibrillar proteins so that upon addition of 
azocasein the marginal increase observed reflected near-
saturation of the enzyme with susceptible substrates. 
2.3.5. Effects of varying ionic strength on the protease 
Chromatography on Sepharose 68 of the triton-washed myo-
fibrils, after dissolution in 0.6 M KCl, resulted in elution 
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EFFECTS OF AZOCASEIN ADDITION ON PROTEASE ACTIVITIES 
AT LOW AND HIGH IONIC STRENGTHS 







1 2 3 4 5 6 
mg Azocasein 
Aliquots of MF fraction (each containing 1 mg protein) 
were incubated independently and in the presen~e of 
increasing amounts of azocasein, at low (o ~ o) and 
high (e ~ e) ionic strengths. Protease activities 
were measured as described in Methods. 
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of chymase in the Vt region (Fig. 2.4). The protease in 
this form degraded azocasein and cytosol protein in a solu-
tion of low ionic strength (measured activity being 25 
nmoles tyrosine/mg protease/3 h), but at high ionic strength 
the cytosol fraction was inhibitory (i.e. where the protease 
released 30 nmoles tyr/3 h with azocasein, only 8 nmoles 
tyr/3 h were released when the enzyme was incubated in the 
presence of equivalent cytosol protein). In addition, 
approximately 60 % of the protease activity remained soluble 
when the column-purified form of the enzyme was dialysed 
against a low-salt buffer and centrifuged at 20 000 g. 
Thus the protease interacted with added cytosol protein in 
two ways, firstly, as protease acting on substrate at low 
salt concentrations, and secondly, as protease blocked by 
inhibitor(s) at high salt concentrations. When separated 
from actomyosin, the protease was largely soluble, but 
when subjected to low ionic strength conditions, a signifi-
cant proportion of the activity behaved in an "actomyosin-
like" manner and was accordingly precipitated. 
2.3.6. Calcium-activated and myofibril-associated protease 
activities in various muscle types 
Calcium-activated protease {CAP) activities were greater 
in the white compared with the red muscle fibre types, while 
the diaphragm (being a muscle containing almost equal pro-
portions of white and red muscle fibres) had activity levels 
closer to that of white fibres (Table 2.4). On the other 
79 
Fig. 2.4 
SEPHAROSE 68 CHROMATOGRAPHY OF MYOFIBRILLAR PROTEINS AT 
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Fraction numbers 
Triton-washed myofibrils were solubilized in 0,6 M KCl, 
1 mM OTT, 1 mM ATP, 50 mM tris-HCl (pH 7,4) and chromato-
graphed on a Sepharose 68 column, previously equilibrated 
















ml fractions were collected, absorbances being read at 280 nm 
and protease activities determined as described in Methods. 
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TABLE 2.4 
CALCIUM-ACTIVATED AND MYOFIBRIL-ASSOCIATED PROTEASE 
ACTIVITIES IN VARIOUS RAT MUSCLE TYPES 
Constant amounts (protein) of MF fraction and PMLS fractions 
(following 'pH 5 step'), prepared from the various rat 
muscles as described in Methods, were subjected to assays of 
their respective myofibril-associated and calcium-activated 
protease activities, as described in Methods. Similar re-
sults were obtained in three separate experiments. 
MUSCLE TYPE CALCIUM-ACTIVATED MYOFIBRIL-ASSOCIATED 
PROTEASE ACTIVITY PROTEASE ACTIVITY 
(nmoles tyrosine/mg/3 h) (nmoles tyrosine/mg/3 h) 
Diaphragm (red + white) 8 57 
Soleus (red) 49 
Heart 2 35 
Psoas (white) 14 17 
EDL (white) 10 18 
Gluteus medius (white) 9 11 
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hand, myofibril-associated protease activity was clearly 
greater in muscles containing red rather than white muscle 
fibres, although the diaphragm once more was noted to have 
high activity levels of this protease in muscle homogenates. 
Cardiac muscle contained a low order of CAP activity and a 
considerable level of the myofibril-associated protease. 
2.3.7. Degradation of myofibrillar proteins 
Despite the tyrosine release observed in the case of MF 
autolysis at low ionic strength, SDS-polyacrylamide gel 
electrophoresis (SOS-PAGE) analysis of the MF pellet before 
and after incubation revealed no detectable change in the 
staining pattern of myofibrillar proteins. However, SOS-
PAGE of the MF fraction incubated at high salt concentrations 
revealed extensive removal of myosin heavy chains with the 
formation predominantly of heavy meromyosin (HMM) - and 
light meromyosin (LMM) - like products (Fig. 2.5). Tropo-
myosin and myosin light chains were also readily degraded 
while actin removal was less marked. The presence of 
azocasein did not alter this degradation pattern, but that 
of cytosol markedly retarded the removal of myofibril-
associated heavy chains under high salt conditions (Fig. 2.5). 
These results point to the presence in the cytosol of an 
endogenous inhibitor(s) which operates effectively only 
when its target protease is soluble. Alternatively, there 
is the less likely possibility that the inhibitor is 11 acti-
vated11 at high salt concentrations. 
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Fig. 2.5 
SDS-POLYACRYLAMIDE GEL ELECTROPHORETIC ANALYSIS OF 
MYOFIBRILLAR PROTEINS, BEFORE AND AFTER PROTEOLYSIS 
a b C d e f g 
-
- ---.. .. ---- ---
Analysis by SDS-polyacrylamide gel electrophoresis of a 
myofibrillar (MF) pellet prepared from mixtures incubated at 
low and high ionic strengths, in the absence and presence of 
added cytosol or azocasein, all as described in Methods. 
(a) = molecular weight standard; (b) + (e) = MF standards; 
(c) = MF 3h, 37°C, low ionic strength; (d) = MF 3h, 37°C, 
high ionic strength; (f) =MF+ azocasein, 3h, 37°C, high 
ionic strength; (g) =MF+ cytosol, 3h, 37°C, high ionic 
strength. 
Molecular weight standards in order of decreasing size: 94 000; 
67 000; 43 000; 30 000 and 20 000 . Arrows in lane (b), from 
above downwards, represent: myosin heavy chain; a-actinin; 
actin; troponin-T; tropomyosin; myosin light chain 1; 
troponin-I; myosin light chain 2; troponin-C. Arrows in 
lane (d) represent heavy meromyosin-like fragment (above) and 
light meromyosin-like fragment (below). 
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2.3.8. Properties of the myofibril-associated protease 
The pH optimum of the MF protease was 8.5, as found by 
numerous other authors (see Introduction) (Fig. 2.6). 
2.3.9. Substrate specificity 
Casin and azocasein were both good substrates for MF-protease, 
with tyrosine measurement by fluorimetry providing a more 
sensitive assay than the colorimetrically assessed release 
of azo groups in the latter case. 
[14 c methyl ] globin and [14 c-NEMJ-MF were degraded to give 
radioactive TCA-soluble fragments when incubated with MF 
fractions derived from skeletal muscle homogenates (Table 
2. 5) . Protease activity measured in this way also followed 
the pattern of ionic strength enhancement and chymostatin 
inhibition revealed by the previously described assay methods. 
However, the use of radio-labelled protein substrates was 
limited in the reconstitution studies in that observed dec-
reases in the amounts of TCA-soluble products formed upon 
combination of various subce]ular fractions reflected either 
tne presence of protein inhibitor(s) or similarly the dilu-
tion of radioactive substrate by competing cold protein 
substrate(s). It was therefore decided to determine prot-
ease activities routinely by measuring tyrosine fluorimetri-
cally; this was in any case a sensitive and highly repro-
ducible assay. Moreover, as tyrosine is present in most 
proteins at a reasonably constant level (Fulks~~, 1975), 
competing 11 added 11 protein substrates did not dilute out the 
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Fig. 2.6 
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6 7 8 9 
pH 
An MF fraction (1 mg protein) in high salt (0,5 M KCl) 
b 
was incubated in 50 mM imidazole buffer (pH 6-7) or 
• 50 mM tris-HCl buffer (pH 7-9); protease activities were 
expressed and measured as described in Methods. 
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TABLE 2.5 
PROTEASE ACTIVITIES WITH LABELLED PROTEIN SUBSTRATES 
One milligram (protein) amounts of MF fraction were incubated 
in the presence of [14 c me thy] gl obi n or [14 c NEM] myofi br i 1 
substrate (at low and high ionic strength), in the absence 
and presence of protease inhibitors. 
were measured as expressed in Methods. 
ACTI V ITV WITH 
[14c METHYL ]GLOBIN 
SUBSTRATE 
(dpm/h) 
MF ( 1 ow i ) 1300 
MF (high i) 3000 
MF+ Chymostatin (high i) 420 
(20 µg/ml) 
MF+ Leupeptin (high i) 2700 
(20 µg/ml) 













product but simply added to it. The presence of inhibitor(s), 
on the other hand, was associated with a drop in the measured 
tyrosine. 
2.3.10. Thermostability (+ ATP) 
In view of the observations made in the case of certain 
proteases concerning thermostability in the presence of ATP 
or citrate (Rose~ .!l, 1979), the ability of the MF protease 
to withstand heating at various temperatures, in the presence 
and absence of these agents was tested; activity was lost 
rapidly in every case. 
2.3. 11. Inhibitors and possible activators 
Amongst the antibiotic inhibitors tested, chymostatin was 
strongly inhibitory, whilst leupeptin and pepstatin had no 
effect even at dose levels of 40 µg/ml (Table 2.6). Both 
the serine protease inhibitors phenylmethyl sulphonyl 
fluoride, and di-isopropylphosphofluoridate were inhibitory 
at concentrations of l mM (Table 2. G). 
Addition of several agents including ca++ (1 mM), ATP (2 mM), 
triton X-100 (1 %) and OTT (1 mM) caused no change in the 
protease activity. A KCl concentration curve revealed 
maximal activity at 0,6 M (data not shown). 
2.3. 12. Treatment of rats with Compound 48/80 
The muscles of rats subjected to the 5-day programme of mast 
cell degranulation f~duced by compound 48/80, contained between 
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TABLE 2.6 
EFFECTS OF INHIBITORS ON MF PROTEASE 
An MF fraction (1 mg per assay) was incubated in the absence 
and presence of known protease inhibitors at various concen-
trations. Protease activities were determined thereafter 
as described in Methods. 
INHIBITOR % INHIBITION 
Chymostatin 8 µg/ml 85 
10 µg/ml 90 
20 µg/ml 90 
PMSF 1 mM 80 
(Phenyl methyl 5 mM 90 
sulphonyl fluoride) 
DFP 1 mM 90 
(Diisopropylphospho- 5 mM 90 
fluoridate) 
NEM 1 mM 70 
(N-ethylmaleimide) 5 mM 75 
Leupeptin 20 µg/ml 0 
40 µg/ml 0 
Peps tat in 20 µg/ml 0 
40 µg/ml 0 
Iodoacetate mM 0 
5 mM 0 
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5-10 % of the MF protease activity present in untreated control 
tissue, independent of the conditions of the assay {Table 2.7). 
SOS-PAGE analysis of the myofibrils revealed no degradation 
of myosin heavy chains in these incubations (Fig. 2.7). 
Histological examination using Giemsa and Bismarck Brown 
stains of skeletal muscle samples from the treated rats con-
firmed tha~ mast cell degranulation was virtually complete 
(Fig. 2.8). 
2.3.13. Cell cultures 
In view of the cellular heterogeneity of intact skeletal 
muscles, the LB line of muscle cells (gift of Prof. 0. Yaffe, 
Weizmann Institute (Israel)) was examined in order to es-
t a b l i s h t h e c e l l u l a r s o u r c e o f my of i b r i l - a s s o c i a t e d p r o t e a s e ( s ) . 
No 'MF protease' activity was detectable (beyond the limit of 
the sensitivity of the assay) in fractions prepared from these 
post-fusion cells (Table 2.5). SOS-PAGE analysis of the MF 
fraction confirmed myosin and actin to be the dominant protein 
components of the incubated material, and this did not show 
evidence of degradation following incubation at low or high 
salt concentrations (Fig. 2.7). 
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TABLE 2.7 
MF fractions from skeletal cell culture extracts and rat 
diaphragm homogenates derived from control and compound 
48/80 treated rats were prepared as described in Methods. 
Protease activities were measured in the absence and presence 
of 2 mg casein, at low and high ionic strength, as described 
in Methods. 
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F i g • 2 • 7 
MYOFIBRIL PROTEIN DEGRADATION (SKELETAL CELL CULTURE EXTRACTS 
AND 48/80-TREATED RAT DIAPHRAGM HOMOGENATES); ANALYSIS BY 
SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
a b c d e f 
Myofibrillar (MF) fractions prepared from skeletal cell culture 
extracts and 48/80-treated rat diaphragm homogenates were incu-
bated at low and high ionic strengths (as described in Methods) 
and thereafter subjected to SDS-polyacrylamide gel electro-
phoresis. 
MF from 48/80-treated rat diaphragm: (a) = MFO'; (b) = MF 3h, 
37°C, low ionic strength; (c) = MF 3h, 37°C, high ionic strength. 
MF from skeletal muscle cells: (d) = MFO'; (e) = MF 3h, 37°C, 
low ionic strength; (f) = MF 3h, 37°C high ionic strength. 
Arrows: Above= myosin heavy chain; below= actin. 
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Fig. 2.8 
MAST CELL DEGRANULATION 
Rat skeletal muscle (i.e. diaphragm) obtained from normal 
rats (left) and 48/80-treated rats (right) - as described 
in Methods - examined histologically by Giemsa stain. The 
mast cells appear deep blue because of staining of granules. 
Slide prepared and photographed by Professor A.G. Rose. 
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2.4. DISCUSSION 
In confirmation of the work of other authors (see Introduction) 
it has been ascertained that rat skeletal muscle contains an alka-
line protease activity which is detectable in the particulate 
fraction of homogenates prepared at low salt concentrations. 
The novel findings in this study are three-fold: 
First, that at low ionic strength, the enzyme is capable of 
degrading native myofibrillar proteins at a relatively slow 
rate, while it also acts on added soluble (cytosolic) protein 
substrates, despite the apparent presence in the latter of a 
proteinaceous inhibitor; 
Second, that when the myofibrils are dissolved at high salt 
concentrations, the alkaline protease enters into solution 
and is optimally active, degrading the myofilaments rapidly 
to free amino acids (e.g. tyrosine) as well as to intermediate 
HMM- and LMM-like fragments. Upon addition of the cytosol 
fraction to this high salt system, however, there is marked 
retardation (inhibition) of the degradative process, because 
the cytosolic inhibitor can apparently interact well with 
the solubilized enzyme under these conditions; 
Third, that the protease is independently liable to precipi-
tate at low ionic strength, and associates with actomyosin 
in muscle homogenates because of this property. It is because 
of this strong association that the term 'myofibrillar alkal-
ine protease' (MAP) has been used in the past (Griffin and 
Wildenthal, 1978). 
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Clues to the true cellular origin of the major protease of 
fresh muscle homogenates became available when certain 
properties (immunologic, physical and biochemical) were 
found to be shared by this protease and the peritoneal mast 
cell-derived, chymotrypsin-like serine protease called 
chymase (Woodbury et~' 1978). Mast cell degranulation 
leads to the loss of most of this alkaline protease activity 
(McKee!!~' 1979; Edmunds and Pennington, 1981), and this 
has been confirmed in this study. 
Chymase activities have previously been noted to be higher 
in red than in white muscle fibre types (Katunuma and Komi-
nami, 1977), the higher level of the alkaline protease 
presu mably reflecting a greater population of mast cells 
in red muscle. · 
These trends have been confirmed in the present work in res-
pect of different muscle types, although calcium-activated 
protease activities showed the reverse pattern viz. a pre-
dominance in white muscle fibre types. 
These results therefore present confirmatory as well as new 
evidence in favour of an exclusive non-muscle cell (viz. mast 
cell) location of the alkaline serine protease of muscle homo-
genates - and would suggest that this enzyme and the mast 
cell chymase are one and the same. This would accord it 
relatively little importance in the study of intracellular 
muscle cell protein turnover. Nevertheless, of interest is 
the fact that this protease can degrade myofibrillar as well 
as cytosolic native proteins. The enhancement of this 
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activity at high ionic strength, together with its inhibition 
under such conditions by endogenous cytosolic inhibitor(s) 
provides a model for the study of protease-substrate-inhibitor 
interactions of other cellular proteases in this manner, 
especially the two-phase features of this system. The mast 
cell is distributed throughout various tissues of the body 
(Riley, 1959) and contains granules in which histamine, 
chymase, heparin and acid hydrolases are packaged (see Pepys 
and Edwards, 1979). The functions of mast cells in terms of 
physiology and pathophysiology at the cellular and molecular 
levels remain to be clarified. 
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CHAPTER 3 
A HIGH MOLECULAR WEIGHT CYSTEINE ENDOPEPTIDASE 
FROM RAT SKELETAL MUSCLE 
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3. l. INTRODUCTION 
Current models for intracellular protein degradation pathways 
in skeletal muscle propose initial, selective proteolytic 
"attacks" which take place outside the lysosomes and which 
are rate-limiting for the overall degradation to the level of 
amino acids (Kominani ~ 2..l_, 1975; Katunuma ~ 2..l_, 1977). 
Several non-lysosomal proteases (soluble and particulate), 
active in the neutral to mildly alkaline pH range, have been 
identified in skeletal muscle and other tissues. These in-
elude the ca++_activated thiol protease which may occur in two 
forms with differing ca++ sensitivity (Reville~ 2..l_, 1976; 
Dayton~ 2..l_, 1981); a serine protease that hydrolyses muscle 
proteins (Koszalka and Miller, 1960), a thiol protease that 
degrades insulin (Duckworth~ 2..l_, 1972) and a particulate, 
"myofibril-associated" protease with an alkaline pH optimum 
(Mayer~~. 1974; Yasogawa ~ ~' 1978; Noguchi and 
Kandatsu, 1970). Data from several laboratories (Paston 
and Almqvist, 1966; McKee~ 2..1, 1979; Libby and Goldberg, 
1980; Edmunds and Pennington, 1981) indicate firstly that the 
"alkaline" serine protease activity of muscle and other tissue 
homogenates, resides predominantly or wholly in mast cells, 
and secondly that ridding the tissue of this activity by means 
of prior mast cell degranulation does not influence signifi-
cantly the overall rate of protein degradation in intact 
muscles (Libby and Goldberg, 1980) or perfused hearts (McKee 
~ 2..1, 1979). 
The aim was to identify enzymes which are definitely localized 
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within muscle cells (rather than in mast cells) and 
which have properties compatible with substrate selectivity 
and physiological regulation known to occur in circumstances 
such as denervation, starvation, diabetes and hyperthyroidism 
Recent reports of an ATP-dependent, multi-component pathway 
of selective protein degradation in reticulocytes (Ciechanover 
et .!]_, 1978; Hershko ~ ~' 1979, 1980, 1981), which 
implicate the heat-stable small protein, ubiquitin as a re-
usable cofactor for de~radation, have stimulated one to 
examine rat skeletal muscles as a source of elements of such 
a system. The properties of an ATP-dependent liver enzyme 
have already been reported (Rose~~' 1979; De Martino 
and Goldberg, 1979). 
The only enzyme of high molecular weight (340000) which has 
been fully described in detail in skeletal muscle is the 
zinc-sensitive aminoendopeptidase (Hydrolase H) isolated 
from rabbit tissue by Okitani ~ ~ (1981); this enzyme 
does not apparently interact with ATP. Two brief reports 
of successful extractions, from human and rat muscles, of 
high molecular weight proteinases, possibly related to the 
reticulocyte and liver enzymes mentioned above, have recently 
appeared; one of these activities was inhibited by ATP 
(Hardy~ .!.l_, 1981), while the other was activated by ATP 
(Etlinger ~ ~, 1981), in a manner apparently involving 
a heat-stable 11 APF-l 11 fraction similar to ubiquitin 
b 
(Ciechanover ~ 2...l_, 1980). 
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In the course of these studies, the problem of "contamina-
tion" of skeletal muscle homogenates (prepared from animals 
not treated with compound 48/80) by the mast cell protease 
(chymase) was overco me by preparation of extracts at low 
ionic strength when chymase coprecipitates quantitatively 
with the myofibrillar fraction sedimented at low speed. 
Supernatant preparation obtained in this way contained no 
detectable chymostati n-inhibitable protease activity (i.e. 
chymase activity) and this fraction, freed of particles 
and membranes by hig h-speed centrifugation, was then used 
as a source of muscle cell-specific proteases and other 
components. 
A soluble cysteineendopeptidase of high molecular weight 
demonstrably differe nt from hydrolase H characterized as 
an amino endopeptidase in rabbit muscle (Okitani £.!_ ~' 
1981), was identified and purified by an apparent factor of 
1000, using column chromatographic procedures. Ubiquitin 
(APF 1: Ciechanover ~ ~' 1980a) was also prepared from rat 
muscle extracts and from rat or human erythrocytes, but no 
ATP-dependent comple mentation on the lines of the reticulo-
cyte system of Hersh ko and co-workers {Ciechanover ~ ~. 1978; 
Hershko ~ ~. 1979) could be detected. A study of chicken 
reticulocytes also failed to reveal ATP-dependent complemen-
tation, although a high molecular weight protease, similar 
to that of the rabbit reticulocyte system (Hershko ~ ~. 
1979) and to that described here, was detected. Neverthe-
less, the enzyme described here may be part of an ATP-
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dependent, multi-component proteolytic system similar to 
that already known to be present in reticulocytes. 
3.2. MATERIALS AND METHODS 
3.2. l. Labelled protein substrates 
[14 c methyl]-globin (2.5 x 10 6 dpm/mg) was prepared by 
labelling bovine haemoglobin according to the method of Rice 
and Means (1971), followed by haem extraction as described 
by Schapira !:.! ~ (1968). In addition, [14c-N-ethyl-
maleimide)-labelled myofibrillar proteins (for preparation, 
see Chapter 2) and [I 125 ]labelled myofibrillar proteins 
( prepared as described by Ciechanover !:.! ~' 1980) were 
additional radio-labelled substrates, tested for their sus-
ceptibilities. 
3.2.2. Fractionation of skeletal muscle extracts 
Long-Evans hooded rats (250 - 350 grams) of both sexes, 
inbred in this laboratory and maintained on standard rat 
chow, were anaesthetized with intraperitoneal injections 
of pentobarbitone and killed by decapitation. Muscles fro m 
both hind limbs were rapidly dissected out, freed of fat and 
connective tissue, weighed, and cut into fine pieces chilled 
in ice. A homogenate (1:4, w/v, in 20 mM sodium phosphate 
buffer, pH 7. 1, also containing 0.5 mM DTT), was prepared 
from the tissue fragments with an Ultraturrax homogenizer, 
operated at setting 6, using 2 x 30 second bursts and with 
continuous cooling in ice. 
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The homogenate was initially centrifuged in the cold at 
800 g for 15 minutes, and the resulting supernatant centri-
fuged twice further, first at 20 000 g for 15 minutes, and 
then at 100 000 g for 60 minutes in a Beckman SW 36 rotor. 
This left a particle- and membrane-free, high-speed super-
natant fraction (HSSN), which was dialysed for 18-24 hrs 
against 250 volumes of the ice-cold homogenized buffer solu-
tion. The dialysed HSSN was then kept at 70°c for 10 
minutes after the addition of ATP (final concentration 2 mM). 
Denatured protein was pelleted by centrifugation at 20 000 g 
for 20 minutes. The supernatant fraction (42 ml) was applied 
to a DEAE-cellulose (Whatman DE 52) column (1,4 x 20 cm), 
previously equilibrated with the homogenization buffer. The 
adsorbed protein was eluted with a linear KCl gradient 
(0 - 0,5 M), and fractions (2 ml) were collected for assays 
of protease activity (see below), and absorbance measurements 
at 280 nm. 
Sepharose 68 (or 48) columns (60 x 0.9 cm) were equilibrated 
in the cold with 50 mM Tris-HCl and 0.5 mM OTT, pH 7.5, 
before the application of various samples at 1-5 % of bed 
volumes. Fractions of l ml were collected at a flow rate 
of 2 ml/h. The columns were calibrated with known marker 
proteins. 
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3.2.3. Protease assays 
Protease activity was routinely measured by the hydrolysis 
of [ 14 c methylJ-globin. Each assay contained 100 mM Tris-
HCl, 5 mM MgC1 2, 0.5 mM OTT, pH 7.5, togetherwiththe radio-
active substrate (1.5 x 10 4 dpm), all in a final volume at 
250 µl. Incubations were performed at 37°c for 60 min, 
after which 200 µl 10% ice-cold trichloroacetic acid {TCA) 
containing 5 mg/ml carrier bovine serum albumin was added 
to each to stop the reactions. Aliquots (200 µl) of the 
supernatant fractions obtained by centrifugation were mixed 
with 5 ml Instagel (Packard Instrument Co., Downer's Grove, 
Illinois, USA) and counted in a Beckman LS 9000 LS Scintil-
lation Counter. Protease activity was expressed as dpm 
released in acid-soluble form per h, after subtraction of 
values for control reactions not containing added enzyme. 
Acid-soluble products of proteolysis were examined by 
chromatography of incubated assay mixtures on a Sephadex 
G25 (30 x 0.9 cm) column, followed by radioactivity analysis 
as described above. 
Assay conditionswith [125 I]labelled myofibrils or [14 c NEM] 
labelled myofibrils were similar, with the exception that 
ass ay mi x tu res cont a i n e d ( 4 x l O 5 ) d pm or ( l . 5 x 1 O 4) d pm 
per test-tube, respectively, when these substrates were 
tested. The rates of enzymatic hydrolysis of L-leucine-2-
naphthylamide (Leu-N-Nap) and a-N-benzoyl-L-arginine 2-
naphthylamide (Bz-Arg-N-Nap) were measured by a modified 
method of Hardy and Pennington {1979). With Leu-N-Nap as 
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substrate, each assay mixture consisted of 50 mM Tris-HCl, 
1 mM EDTA, 0.5 mM substrate and sample in a final volume of 
0.5 ml at pH 7.5. After incubation for l hr at 37°c, 2 ml 
of ice-cold ethanol was added to each tube and the liberated 
naphthylamide measured fluorimetrically (excitation 339 nm, 
emission 403 nm). A standard curve using pure naphthyl-
amine was obtainedand the enzyme activity accordingly expres-
sed as nmoles naphthylamide released/min. In the case of 
assay mixtures containing Bz-Arg-N-Nap as substrate, the 
same procedure was followed but in these instances the sub-
strate concentration was 2 mM. 
Protein determinations were performed by the method of Lowry 
~ ~ (1951), as modified by Hartree (1972), with bovine 
serum albumin as standard. 
3.2.4. Gel electrophoresis 
An aliquot of the purified enzyme from the Sepharose 68 
column was concentrated by TCA precipitation and subjected 
to SDS-polyacrylamide gel electrophoresis according to the 
method of Porzio and Pearson (1977). 
3.2.5. Chicken reticulocytes 
Reticulocytosis (80 - 90 % of total cell count) was induced 
in chickens by the injection of phenylhydrazine as described 
by Etlinger and Goldberg (1977). 
103 
3.2.6. Reticulocyte lysate 
Cells obtained by centrifugation of heparinized blood at 
2000 rpm were washed twice in ice-cold saline and incubated 
(37°c, 2 h) with 0.2 mM 2,4-dinitrophenol and 20 mM deoxy-
glucose, to deplete cellular ATP (Hershko ~ ~, 1978). 
Following additional washings, the cells were lysed with 
1,6 volumes of deionized water containing 1 mM OTT, and 
particulate material removed by centrifugation at 80 000 g 
for 90 minutes. 
3.2.7. Fractionation on OEAE-cellulose 
All operations were at 0-4°C. Thirty ml lysate was applied 
to a 1.5 x 12 cm column of OEAE cellulose (Whatman OE-52) 
equilibrated with 20 mM sodium phosphate (pH 7. l) containing 
0.5 mM OTT. Adsorbed proteins were eluted with 50 ml of 
the above buffer containing l mM OTT. The last two-thirds 
of this material containing haemoglobin were collected and 
designated fraction I (ubiquitin) (Ciechanover ~ .!.l_, 1978). 
The remaining protein was then eluted with 70 ml of a 
solution containing 10 mM Tris-HCl, 0.5 mM OTT, 0.5 M KCl 
(pH 7. l). Solid ammonium sulphate was added to 90% satura-
tion (65 g per 100 ml of solution), mixed well, and the sus-
pension kept in ice for 30 minutes. Precipitated protein 
was collected by centrifugation and taken up in 2 ml of a 
solution containing 50 mM Tris-HCl, 0.5 mM OTT (pH 7.5). 
This material was called fraction II. One ml of this 
fraction was applied to a Sepharose 48 column (60 x 0.9 cm) 
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and l ml fractions were collected at a flow rate of 2 ml/h. 
Protease activities of the various preparations and frac-
tions were determined using [14 c methyl]globin as substrate -
assay conditions and procedures being the same as for the 
skeletal muscle preparations described above. Protease 
activities of the various fractions independently and upon re-
constitution were determined in the presence and absence of 
5 mM ATP. 
3.2. 8 . Materials 
[14 c-methyl]-formaldehyde (16.7 mCi/nmol) was obtained fro m 
Amersham, England. Chymostatin, leupeptin and pepstatin 
were purchased from the Peptide Institute, Protein Research 
Founcation, Japan. 
OTT, ATP, creatine kinase, creatine phosphate, compound 48/80, 
L-tri-iodothyronine, L-Leu-N-Nap, Bz-Arg-N-Nap and naphthyl-
amine were obtained from Sigma Chemical Company, USA, and all 
other chemicals used were Analytical Reagent grade. 
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3.3. RESULTS 
3.3. 1. Purification of protease 
The heat-treated, high-speed supernatant (HSSN) contained 
little protease activity in the presence or absence of ATP 
(Table 3.1). Dialysis of this fraction (dialysis tubing with 
a 3 500 molecular inclusion limit) caused a 10-fold increase 
in activity. This suggested that dialysable endogenous 
inhibitors were present in the supernatant; such inhibition 
could also have been 11 apparent 11 (removal of competing peptide 
substrate(s)). No inhibitor could be detected, however, in 
a reconstitution experiment using an undialysed HSSN prepara-
tion (see below). As zinc chloride was subsequently shown 
markedly to inhibit the purified enzyme (Table 3.2), the effect 
of a zinc ion chelator (imidazole) on the undialysed HSSN 
fraction was studied. This failed to enhance the tissue 
activity (results not shown), suggesting that the removal of 
zinc ions was not the explanation for enhancement following 
dialysis. After the heating step, there was a further in-
crease in specific activity of the extract, with an extensive 
loss of total protein (Table 3.1). 
When the dialysed and heat-treated fraction was applied to 
an anion exchange column (DEAE-cellulose), all the red-
pigmented protein (presumably residual myoglobin) was washed 
off the column; this contained no protease activity. A 
virtually colourless band of protein remained adsorbed onto 



















































































































































































































































































































































































































































































































































































































































































































































































































































salt gradient and all th.e protease activity appeared between 
KCl concentrations of 0.20 and 0.30 M (Fig.3. 1). This acti-
vity peak (representing about 2% of the total protein applied 
to the column) was pooled and the protein precipitated over-
night at 90 % saturation with ammonium sulphate. The result-
ing pellet was taken up in 2 ml 50 mM Tris-HCl containing 
0.5 mM OTT pH 7.5, and applied to a Sepharose 68 (or 48) 
column (Fig. 3.2). The activity peak eluted with a Kav 
indicative of an aproximate molecular weight of 500 000. 
It should be noted that the ammonium sulphate step caused 
an appreciable loss of apparent enzyme activity which could 
not be recovered subsequently. Other methods of protein 
concentration (not described) caused a similar loss. The 
final apparent purification was 1000-fold over the dialysed 
HSSN; the yield through the two column steps was 95% (Table 
3. 1). (The question of the quantitativeness of the assay 
procedure is addressed below). The same Kav was obtained 
when the Sepharose 68 column was run at high ionic strength 
(0.6 M KCl) or in the presence of 0.5 % Triton X-100, and the 
elution behaviour was also independent of the presence or 
absence of OTT. These find i ngs suggest that the enzyme is 
genuinely of high molecular weight. 
When the heat-step was omitted from the purification scheme, 
the Sepharose 68 (or 48) protease activity profile revealed 
two peaks; one in the 500 000 molecular weight range (which 
was also routinely observed when the heat-step was included) 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The latter activity was pepstatin-inhibitable, and had a pH 
optimum around 5.0; it presumably represented a protease (s) 
of lysosomal origin, probably cathepsin D. Treatment of 
this peak with Triton-XlOO failed to produce a shift in its 
position of elution, indicating that this was not a membrane-
associated protease activity. 
3.3.2. Distinction of protease from aminoendopeptidase 
The undialysed HSSN fractio catalysed significant hydrolysis 
of L Leu-N-Nap at pH 7.5. This aminopeptidase activity was 
also adsorbed to the DEAE cellulose column and eluted at 
0.20 M KCl in a peak which overlapped extensively with the 
[ 14 c-methyl]-globinase activity. Measurement of enzyme 
activity in each of the fractions from the Sepharose 68 
column against [ 14 c-methy1J-globin and the aminopeptide sub-
strate gave two well-defined but separate peaks of activity -
a 500 000 molecular weight peak of protease activity and a 
second enzyme, of approximate molecular weight 350 000, which 
degraded Leu-N-Nap (Fig. 3.3). The latter enzyme was part-
ially inhibited by iodoacetate (10 mM) and by leupeptin 
(0.5 mM) and markedly inhibited by Zinc ions (Table 3.3). 
The optimal pH for this activity was 7.5 and the enzyme 
hydrolysed Bz-Arg-N-Nap less well than Leu-N-Nap. This 
entity was thus almost certainly the aminoendopeptidase, 
hydrolase H recently described in rabbit muscle extracts by 





























































































































































































































































































































































































































































































































































































































HYDROLASE H: EFFECTS OF INHIBITORS ON ACTIVITY OF 
HYDROLASE H 
Aliquots of the pooled fractions from the Sepharose 6B column 
showing activity towards Leu-N-Nap were assayed in the absence 
and presence of protease inhibitors; activity towards Leu-N-Nap 
was determined as described in Methods. 
Inhibitor Relative act i vity towards 
Leu- N- Nap 
None 10 0% 
Iodoacetate (10 mM) 5% 
ZnS0 4 ( 1 mM) 5% 
Leupeptin ( 2 0 µg/ml) 30 % 
(40 µg/ml) 20 % 
Chymostatin ( 2 0 µg/ml) 100 % 
(40 µg/ml) 10 0% 
Pepstatin (20 µg/ml) 100 % 
(40 µg/ml) 100 % 
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3.3.3. Validity of the radiometric assay 
It was noted that the protease activities of impure enzyme 
preparations were not linear with protein concentration, 
while the column purified material showed a linear relation-
ship with increasing enzyme concentrations (Figs. 3.4, 3.5, 
and 3.6). A time course study over two hours revealed that the 
routine incubation period for the two assays was well within the 
period of constant rate of activity of the protease (Fig. 3.7). 
In addition, there was a large increase in activity caused 
by dialysis of HSSN preparations (see above). These pheno-
mena could have been caused by endogenous inhibitors or by 
the presence of contaminating proteins 'competing' with the 
I 14 c!-substrate. Accordingly, an undialysed HSSn fraction 
(2 ml volume) was directly applied to a Sepharose 68 column 
after which the peak with high protease activity was pooled. 
This enzyme was then assayed in . the presence and absence of 
100 µl aliquots of all the other inactive fractions to assess 
whether specific endogenous inhibitors were present, or 
whether native proteins competed randomly with the radioactive 
substrate in the routine assays. Decreases in protease acti-
vity correlated generally with the total amounts of protein 
added in other fractions, and there was no significant indi-
cation of a well-defined peak of inhibition (Fig. 3.8). 
(Precise superimposition of the protein and 'inhibition' 
curves was not possible in areas of activity overlap due to 
the protease peak). The results were thus in keeping with 
the idea that native proteins present in the extracts were 





EFFECT OF INCREASING AMOUNTS OF HIGH-SPEED SUPERNATANT 
ON ACTIVITY OF PROTEASE(S) 
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Increasing amounts (protein) of dialysed (•~•) and 
undialysed (o~o) HSSN fractions were assayed with 
[
14 c methyl ] -globin; protease activity, determined 



























Increasing amounts ( µ 1) of the DEAE cellulose-purified 
protease were assayed with [ 14 c met hyl ] -globin, as 
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Increasing amounts (~1) of the Sepharose 68-purified 
enzyme were assayed with [14 c methyl]-globin, as 
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The purifjed enzyme was assayed at 37°C and the TCA-soluble 
14 c-fragments released from [14 c methyl]-globin at various 
time intervals measured as described in Methods. 
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Fig. 3.8 
APPARENT ABSENCE OF A SPECIFIC INHIBITOR OF THE PROTEASE 











// •\o 0. \ 
1r / • \ ,r \0 
1: I s .\--a-!!--
40 50 
Fractions 
An undialysed HSSN fraction from l g of homogenized leg muscle 
was chromatographed on Sepharose 6B (0.9 x 60 cm) previously 
equilibrated with 50 mM tris-HCl, 0.5 mM DDT (pH 7.5), as 
described in Fig. 3.2. The protease peak was identified and 
pooled. Samples of this enzyme were assayed in the presence 
and absence of 100 µl aliquots of the whole range of other 
column fractions, and thepercentage inhibition (if any) (•-•) 
was calculated in each case. Absorbance at 280 nm (o~o). 
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that no particularly effective inhibitor was present. It 
is noteworthy that no low molecular weight peak of inhibition 
was noted (Vt region of the column eluates). The activation 
caused by dialysis of the HSSN fractions (see above) cannot 
therefore be explained by ridding the fraction of low molecu-
lar weight protease inhibitor(s). 
3.3.4. Effects of ATP 
Enzyme activities throughout the purification procedure were 
measured in the presence or absence of 2 mM ATP and an ATP-
regenerating system consisting of creatine phosphate and 
creatine kinase. Both the DEAE activity peak and the 
Sepharose activity peak showed a variable 'stimulation' in 
the presence of the ATP system. This inconsistent effect 
was further examined by pre-incubating the purified enzyme 
with and without the ATP system for 60 minutes at 37°c and 
42°c, in the absence of exogenous substrate. Thereafter 
[ 14c-methyl] -globin was added as well as ATP to those tubes 
lacking it, and the remaining activity was then assayed at 
37°c for 60 minutes. The loss of activity was 20 % when the 
pre-i ncubation was conducted at 37°c, and 90 % at 42°c, in 
t he absence of ATP. Pre- i ncubation in the presence of ATP 
markedly protected the activity (Fig. 3.9). ATP concentra-
tions as low as 0. 1 mM stabilized the protease to roughly 
the same extent. Citrate at 50 mM, creatine phosphate 20 mM, 
EDTA 1 mM and the non-hydrolysable ATP analogue, Sy-methylene 
ATP failed to stabilize the enzyme. 
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Fig. 3.9 
EFFECT OF ATP ON THERMAL STABILITY OF THE PROTEASE 
A B 
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Samples of enzymes purified by column chromatography (Fig. 
3.2) were pre-incubated at 37°C (A) and 42°C (B) for 30 and 
60 min, in the presence (•) and absence ( 6 ) of ATP. After 
this, the activity of the remaining enzyme was assayed at 
37 °C as described in Methods. 
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3.3.5. Other properties 
The pH range of the protease with radioactive globin extended 
from 6.5 to 9.0 but the optimum was 7.5 (Fig. 3. 10). 
The purified enzyme was unstable in the frozen state, losing 
80 % of its activity within 4 days of freezing. However, 
when the enzyme was kept at 4°C, no loss of activity was ob-
served over the first seven days, following which a gradual 
diminution in activity was noted, reaching 60 % of the initial 
activity at 14 days. 
The protease activity eluted ahead of ferritin from Sepharose 
48 or 68 columns (calibrated with marker proteins at high 
molecular weight), at a position consistent with a molecular 
weight of 500 000 for the native complex (Fig. 3.2). 
The protease appeared to contain an essential thiol group, 
since dithiothreritol and cysteine addition enhanced its 
activity, while N-ethylmaleimide (NEM) and p-chloromercuri-
phenylsulphonic acid (PCMPS) were inhibitory (Table 3.2). 
Chymostatin, leupeptin and pepstatin had no effect at concen-
trations known to inhibit the activities of entities such as 
the mast cell serine protease (Libby and Goldberg, 1980), 
Ca++_activated protease (Reville~~, 1976) and the lyso-
somal acid hydrolases cathepsins B, H, Land D (Barrett, 1977). 
Znc1 2 (1 mM) markedly inhibited the enzyme and imidazole 
(25 mM), a zinc chelating agent, caused a moderate increase in 
activity (Table 3.2). 
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Fig. 3.10 
pH OPTIMUM OF PROTEASE 
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An enzyme preparation obtained as shown in Fig. 3.2 was 
incubated for 60 min at 37°C with 14c methyl ] -globin, 
in 25 mM imidazole-HCl buffer (pH 6-7) and tris-HCl 
buffer (pH 7-9); labelled TCA-soluble products were 
estimated as described in Methods. 
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The protease appeared to be an endopeptidase since analysis 
of the TCA-soluble products on Sephadex G25 revealed radio-
active peptide ranging in molecular weight from 1500 to 
15000 (Fig. 3.11). 
3.3.6. Substrate selectivity 
In addition to [ 14 c methyl]-globin, which may be considered 
to be a denatured but soluble protein, the enzyme preparation 
attacked denatured casein and azocasein, because addition of 
these proteins to the assay markedly diminished the production 
of radioactive products from the globin substrate (Fig. 3. 12). 
Addition of bovine serum albumin did not 11 dilute 11 the product 
radioactivity in standard assays and this protein may thus 
not be attacked by the endoprotease. 
In addition, the activity of a sample of hexokinase assayed 
by the method of Crabtree and Newsholme (1972) was signifi-
cantly inactivated (>50 %) when it was pre-incubated for 
60 min at 37°C with 10 µg of the high molecular weight 
protease (Fig. 3.13). 
[ 1 4 C N E M J - 1 ab e 1 1 e d my o f i b r i 1 1 a r p rot e i n s w e re a 1 s o a t ta c k e d 
by the protease, but this substrate was not routinely used 
because the amounts of TCA-soluble fragments formed were 
s ma l l . [ 1 2 5 I) - l a b e 1 l e ·d my o f i b r i 1 1 a r p rote i n s w e re mo re 
susceptible to attack by the protease, but the background 
activity in this case was higher and the half-life of the 
label was shorter. For these reasons [ 14c methyl]globin 








SIZE ANALYSIS OF PROTEASE DIGESTION PRODUCTS 
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Fractions 
A standard assay mixture constituted as described in 
Methods and containing enzyme purified as in Fig.3.2, was 
incubated and stopped by addition of TCA. After centri-
fugation, the supernatant was chromatographed on Sephadex 
G25, and radioactivity in the fractions (0,4 ml each) was 














EFFECTS OF ADDITION OF CASEIN OR BOVINE SERUM ALBUM I N 
IN THE ACTIVITY OF THE PURIFIED ENZYME 
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The column-purified protease was assayed in the absence 
and presence of varying amounts of bovine serum albumin 
( ~~ ~ ) or casein (•~•); protease activities were 
























Fresh rat skeletal muscle homogenate containing a known 
amount of hexokinase activity was incubated in the presence 
of 10 µg bovine serum albumin (o) or in the presence of 
10 µg purified high molecular weight protease (•) at 37°C 
for 60 minutes, after which the remaining hexokinase 
activity was determined as outlined in Methods. 
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3.3. 7. Proteolytic system in chicken reticulocytes 
The reticulocyte lysate contained significant 14 c-methyl 
globinase activity at neutral pH, but this was not enhanced 
by ATP (Table 3.4). These results were unlike those of 
Ciechanover ~ ~ (1978), where the protease activity in the 
rabbit reticulocyte lysate was markedly enhanced in the 
presence of ATP. 
Fraction I contained no detectable protease activity, while 
fractionation of the DE-adsorbed material (Fraction II) on 
Sepharose 4B revealed an activity peak in the 500 000 mol. 
wt. range and a smaller peak in the excluded volume (V
0
) 
(Table 3.4). The activity of fraction II was not enhanced 
by ATP and addition of fraction I to fraction II did not 
result in ATP-dependent cooperativity (Table 3.4). 
3.3.8. Absence of ubiquitin effect 
Crude preparations of fraction I (ubiquitin) from rat skele-
tal muscle, rat erythrocytes and human erythrocytes (obtained 
a 
by the method of Ciechanover ~ ~' 1980) did not show ATP-
dependent complementation when assayed with reticulocyte 
fraction II. Similar attempts at complementation between 
ubiquitin and the high molecular weight rat muscle protease 
at various levels of purification, in the presence and 
absence of ATP, did not show any of the features of a multi-
component, ATP-dependent system. 
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TABLE 3.4 
PROTEASE ACTIVITIES IN CHICKEN RETICULOCYTE EXTRACTS 
Protease activities (determined in the presence and absence 
of ATP) were measured in reticulocyte extracts (at all the 
levels of purification), all as described in Methods. 
Reconstitution of the fractions was also studied to detect 




Fractions I + II 
V
0 
Peak (Seph 48) 


















SOS-POLYACRYLAMIDE GEL ELECTROPHORETIC ANALYSIS OF 
THE ENDOPROTEASE 







An aliquot of the purified endoprotease from the Sepharose 
68 column was concentrated and analysed on a SDS-poly-
acrylamide slab gel (see Methods). The molecular weights 
of various protein standards are indicated in the figure. 
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Although no complementation was obtained in the case of rat 
muscle and chicken reticulocyte extracts, a high molecular 
weight protease (~500 000 daltons) was isolated from each of 
these extracts. These proteases all had similar molecular 
masses, and also shared other properties (e.g. thermal stabi 
lization by ATP). 
3.3.9. Subunit structure of endoprotease preparation 
Analysis of the purified enzyme by electrophoresis on a SDS-
polyacrylamide slab gel revealed two subunits with approximate 
molecular weights of 100 000 and 52 000 representing most of 
the protein (Fig. 3. 14). A number of bands in the molecular 
weight region between 24 - 30 000 were also present. 
3.4. DISCUSSION 
The most active protease activity 'detectable' at neutral or 
mildly alkaline pH in rat skeletal muscle extracts is a chymo-
trypsin-like serine protease (chymase) (Mayer et~' 1974). 
This protease, which appears to co-precipitate with myofibril-
lar proteins at low salt concentrations, is solubilized at 
high ionic strengths and in this state is optimally active 
against myofilaments as well as against exogenous substrates 
(e.g. casein). The protease is chymostatin-sensitive and 
its activity disappears from tissues in which the mast cells 
have been degranulated (McKee~~' 1979; Libby and Gold-
berg, 1980; Edmund and Pennington, 1981). 
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The soluble component of liver extracts, prepared in low 
ionic strength buffers, contains a high molecular weight 
alkaline protease (Rose~~' 1979; De Martino and Gold-
berg, 1979); more recently, a large enzyme called Hydrolase 
H has also been isolated from rabbit skeletal muscle by 
Okitani ~ ~ (1981). In addition, Hershko et al have 
identified a high molecular weight protease, in reticulocyte 
extracts, which forms part of a multi-component system for 
the degradation of denatured globin in an ATP-dependent manner 
(Hershko ~ ~' 1979, 1980, 1981). All these activities are 
much less active than the chymase with respect to most protein 
substrates tested. 
The data presented here concern the properties and purifica-
tion of a 500 000 molecular weight protease in the membrane-
free fraction of skeletal muscle homogenates. The enzyme 
is optimally ac t ive at a pH of 7.5 and is not inhibited by 
a range of Umezawa antibiotic inhibitors nor stimulated by 
++ Ca , even in t he presence of EGTA. This latter finding 
eliminates the possibility that one of the Ca++_requiring 
thiol protease is involved, and leupeptin inhibition shown 
by such enzymes was also absent (Dayton~~' 1981). 
Other enzymes which are excluded from consideration are 
chymase (chymostatin-inhibited), the aminopeptidase Hydrolase 
H (Okitani ~ !l, 1981) which is inhibited by leupeptin (and 
was separated from thehigh molecular weight protease) and 
the various cathepsins B, D, Land H (Barrett, 1977). 
Stimulation by thiol agents and inhibition by PCMPS and NEM 
point to an active thiol group. 
133 
ATP stimulation of protease activity in enzyme fractions 
at various levels of purification was variable and slight. 
However, the heat stability of the enzyme at 42°c was very 
significantly enhanced by the nucleotide even at concentra-
tions as low as O. l mM, indicating that the enzyme had some 
kind of binding site for ATP. The ATP-stabilized liver 
protease studied by Rose~ .!}_,(1979) was also stabilized 
by citrate; this polyanion was ineffective in preventing 
the thermal denaturation of the enzyme here described. 
Nevertheless, the muscle-derived enzyme had several other 
properties in common with the liver enzymes described by De 
Martino and Goldberg (1979) and by Rose~.!}_ (1979). 
Thus its pH optimum was also between 7 and 8, and the activa-
tion by thiol compounds, inhibition by NEM and PCMPS, heat 
stabilization by ATP and endoprotease character were all 
similar. This enzyme differed from that of De Martino and 
Goldberg (1979), however, in that their enzyme showed a more 
marked inhibition caused by iodoacetate (mild or absent in the 
enzyme here reported), a marked stimulation (almost 100%) 
caused by ATP (slight and variable in this case) and enhance-
ment of ATP dependence by addition of the non-ionic detergent, 
Triton X-100 (absent in this case). Again the high molecular 
weight (450 000) protease characterized in reticulocyte ex-
tracts requires ATP for thermal stabilization and participates 
together with ubiquitin in a multi-component, ATP-dependent 
system, that catalyses the selective degradation of denatured 
globin to the level of amino acids. It is noteworthy that 
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albumin is attacked by the reticulocyte system while the 
muscle enzyme did not apparently act on this protein. Since 
Sy-methylene ATP failed to stabilize the muscle protein, a 
possible role for ATP hydrolysis may eventually be found for 
a system of which this high molecular weight protease may be 
a part. 
There appear to be important differences between the high 
molecular weight proteinase here described and that isolated 
by Hardy~~ (1981) from human skeletal muscle. Examples 
are the rapid action of the former on casein and globin, the 
absence of aminopeptidase activity, lack of ca 2+ stimulation, 
marked OTT sti mulation, and absence of inhibition by ATP. 
No data are available in respect of the powerful zn 2+ inhi-
bition and the heat-stabilization afforded by ATP, which are 
features of the enzyme outlined in this report. 
The crude muscle enzyme briefly described by Etlinger and 
co-workers (1981) displays marked activation by ATP which is 
diminished by haemin addition, and is apparently dependent 
on a ubiquitin-like fraction also obtained from muscle; no 
other details are available. Another cysteine proteinase 
isolated from smooth muscle has been found to have a very 
large size (1300 000) and a mildly alkaline pH optimum (Roth 
~ ~' 1981). Both casein and albumin are attacked and Zn 2+ 
inhibits weakly (30% at l mM); no effects of ATP were re-
ported, either in terms of activation or stabilization of the 
very heat-labile enzyme. 
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No specific inhibitor was detected in the high-speed super-
natant fraction, but endogenous native proteins competed 
with the denatured radiolabelled substrate for degradation. 
The role of the enzyme is thus not limited to the degradation 
of 11 abnormal 11 or partially denatured proteins, as appears to 
be the case in the reticulocyte system (Hershko ~ ~' 
19 80) . 
A high molecular weight, cysteine endopeptidase from rat 
skeletal muscle present in the particle-free fraction of 
muscle extracts and optimally active at pH 7.5 has thus been 
characterized. Because of the significant thermal stabili-
zation of the enzyme caused by ATP, this protease may form 
part of a multi-component ATP-dependent proteolytic system 
similar to that reported in reticulocytes (Hershko ~ ~' 
1979, 1980, 1981; Ciechanover et~' 1980, 1981). 
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CHAPTER 4 
THE RELATION BETWEEN IN SITU PROTEOLYSIS 
IN SKELETAL MUSCLE AND THE IN VITRO 
ACTIVITY OF CERTAIN PROTEASES 
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4. 1. INTRODUCTION 
The attempts of biochemists to understand the basis of 
protein degradation have so far resulted in the isolation 
and characterization of several lysosomal and non-lysosomal 
proteases, in the case of many species of animals and a 
variety of muscle types. Data on the interaction of such 
entities with endogenous inhibitors have also permitted 
concepts of controlled proteolysis to develop. An exten-
sion of these approaches is the correlation of~ situ 
rates of protein degradation with assayable activities of 
proteases in the case of physiological or pathological 
perturbations. Such experiments are based on the concept 
of a rate-limiting enzyme step for the overall degradative 
process in skeletal muscle. In essence, the most decisive 
advance in this field will be the identification of such a 
critical protease(s) and the determination of regulatory 
mechanisms which control its activity. 
One therefore has set out to measure in situ proteolytic 
rates of isolated, intact soleus (red) and extensor digitorum 
longus (white) skeletal muscles derived from control, dener-
vated, starved, diabetic, hyperthyroid and cortisol-treated 
animals, and also from rats in whom mast cell degranulation 
had been produced by treatment with compound 48/80. In each 
case a comparison was made between~ situ proteolytic rates 
and the in vitro activities of chymase as well as the high 
molecular weight protease. 
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4.2. MATERIALS AND METHODS 
4.2. 1. Preparation of rats. 
Long-Evans hooded rats (100 gm body mass) were injected intra-
peritoneally with an anaesthetic dose of pentobarbitone 
sodium and sacrificed by decapitation. The rats were main-
tained, before experimentation, on standard laboratory chow 
and were injected intra-peritoneally with various agents (see 
below) to alter degradation rates. 
4.2.2. Physiological manipulation to enhance protein 
degradation. 
(a) Hyperthyroidism: Rats received catabolic doses of 
L-tri-iodothyronine (Carter~~, 1981) 25 µg/lOOgm body wt., 
injected daily intraperitoneally over 14-18 days. 
(b) Denervation: Unilateral sci ·atic nerve denervation was 
performed (Goldspink, 1976) with the contra-lateral hind-
limb being the control. (c) Diabetes Mellitus: Diabetes 
was induced (Mayer~~' 1974) with alloxan (16 mg/lOOgm) 
injected intra-peritoneally as a single dose and rats sacri-
ficed on Day 4. (d) Starvation: This was carried out for 
a 48 h period. (e) Hypercortisolism: Hydrocortisone 
(5 mg/100 gm) was injected daily intra-peritoneally for 5 days 
prior to sacrifice (Goldberg, 1980). 
4.2.3. Mast cell degranulation. 
Degranulation of mast cells was induced according to the 
method of Pastan and Almqvist (1966) and Riley (1959) - see 
Chapter 2. 
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4.2.4. In vitro enzyme activities. 
Hamstring muscles (0,5 gram) from the various rats were 
dissected out, freed of fat and connective tissue and homo-
genized in 5 volumes of 50 mM Tris-HCl, 0,5 mM OTT pH 7,5. 
A high speed supernatantfraction (HSSN) and a myofibrillar, 
sedimentable fraction (MF) were prepared as described in 
Chapters 3 and 2, respectively. 
The various HSSN fractions were applied to Sepharose 68 
columns (60 x 0,9 cm), previously equilibrated with the 
homogenization buffer, the fractions containing the activity 
peak against [ 14 cJmethylglobin (for details of assay condi-
tions see Chapter 3) were pooled and the activity of this 
pooled peak determined and expressed as total and specific 
activity. Lowry proteins were measured with bovine serum 
albumin as standard (Lowry 1951). These activities rep-
resented the high molecular weight protease activity in these 
HSSN fractions. 
Myofibril-associated protease ( 'Chymase') activities were 
determined at high ionic strength (for details see Chapter 
2), and expressed as nmoles tyrosine/mg MF protein/3 h. 
4.2.5. Tissue incubations. 
Net rates of proteolysis in intact extensor digitorum longus 
(EDL) and soleus muscles were assessed generally according 
to the method prescribed for rat diaphragm by Fulks 
et al ( 1 9 7 5 ) • A preincubation for 30 minutes was 
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followed by incubation of the muscles for 2 h in Krebs-
Ringer bicarbonate buffer gassed with 95 % 02/5 % CO 2 . Incuba-
tions were terminated with TCA (10 % final concentration), 
the samples were centrifuged, and the tyrosine contents of 
the supernatants determined fluorimetrically (see above). 
Cycloheximide (0,5 mM) was added to some systems to test 
whether there was a need to block re-utilization of amino 
acids for protein synthesis in order to obtain accurate 
values for overall degradation rates. 
4.2.6. Materials. 
Dithiothreitol (OTT), EGTA, Compound 48/80 and L-triiodo-
thyronine were obtained from Sigma Chemical Co. All other 
chemicals used were of Analytical Reagent grade. 
4.3. RESULTS 
4.3.1. In situ proteolysis 
Rates of proteolysis in intact EDL (white fibre type) and 
soleus (red fibre type) muscles from fed normal rats were 
not significantly different in the presence or absence of 
cycloheximide. 
Pretreatment for 5 days with daily injections of Compound 
48/80, the mast cell degranulator, did not cause any alter-
ation in the basal rates of~ situ proteolysis (Table 4.1), 
and the inhibition of these rates caused by chymostatin and 





















































































































































































































































































































































































































































































































































































































































subjected to mast cell - degranulation, compared with 
matched controls. 
Furthermore, denervation resulted in enhanced proteolytic 
rates of the same magnitude in the case of normal rats as 
was found in the case of rats after mast cell degranulation, 
suggesting that the enhanced rates of proteolysis caused by 
denervationwere not mediated by changes in chymase activity. 
With the exception of control, 48/80 treated and hydro-
cortisone-treated rats, all other gro~ps (diabetes mellitus, 
hyperthyroidism, denervation, starvation) were associated 
with enhanced rates of proteolysis in the case of both white 
and red muscle fibre types studied (Tables 4.2 and 4.3). 
It was noted that four days• denervation resulted in greater 
increase in proteolytic rates in EDL compared with soleus 
muscles (Table 4.1), while the soleus lost more weight 
(Table 4.4) - indicating that the greater loss in mass 
undergone by red muscle may have been due to an associated 
reduction in protein synthesis. By concomitant measurement 
of protein synthesis and degradation in such intact isolated 
muscles, Goldspink (1976) has shown that while the EDL is 
accompanied by greater degradation following denervation, 
the soleus undergoes less protein synthesis (at 4 days• 
denervation), accounting for these mass changes. 
The ratio of heart weight/body weight progressively dec-
reased with increasing body weight in all groups studied, 
with the exception of the hyperthyroid animals, where this 
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TABLE 4.2 
PROTEIN DEGRADATION IN INTACT MUSCLES AND "MYOFIBRILLAR 
PROTEASE" ACTIVITY 
Protein degradation rates in intact soleus and EDL muscles 
from control and treated rats were determined as described 
in Methods. MF fractions from hindlimb muscles of the same 
rats were prepared and the MF protease activities determined 
as described in Methods. 
GROUP PROTEIN DEGRADATION MF-PROTEASE 
(nmoles tyrosine/mg/2 h) ACTIVITY 
Expt. No. = 4 (+ S.D.) (nmoles tyrosine/ 
mg/3 h) 
Soleus EDL 
Control 0,31 (±0,06) 0,23 (±0,02) 56 (±3) 
Compound 48/80-treated 0,30 (±0,02) 0,21 (±0,02) 3 (±0,8) 
Hypercort i so 1 ism 0,32 (±0,04) 0,23 (±0,03) 53 (±3,6) 
Denervation 0,55 (±0,08) 0,56 ( ±0 , 11 ) 56 (±5) 
Starvation 0,87 (±0,08) 0,69 (±0,19) 55 (±4) 
Hyperthyroidism 0,49 (±0,02) 0,37 (±0,02) 56 (±3,4) 
Diabetes Mellitus 0,47 (±0,10) 0,30 (±0,06) 55 ( ±4 '1) 
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TABLE 4.3 
PHYSIOLOGICAL MODULATION OF PROTEOLYTIC RATES IN SKELETAL 
MUSCLES: HIGH MOLECULAR WEIGHT PROTEASE ACTIVITIES 
Proteolytic rates were measured in intact soleus and EDL muscles, 
as described in Methods. The high molecular weight protease 
activities in hindleg skeletal muscles dissected from control, 
compound 48/80-treated, starved, hyperthyroid, diabetic and 
denervated rats, were determined in (unheated) high-speed 
supernatant preparations subjected to Sepharose 68 chromato-
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% MASS CHANGE IN SOLEUS AND EDL MUSCLES IN THE TREATED 
ANIMAL GROUPS COMPARED WITH MATCHED CONTROLS 
The masses of intact soleus and EDL muscles in the animal 
groups studied were compared after complete dissection with 
those of matched controls. 
SOLEUS EDL 
Starvation - 40% - 37% 
Denervation - 21 % - 12% 
Diabetes Mellitus - 14% - 16% 
Hyperthyroidism - 18% - 17% 
Hypercortisolism 0% 0% 
Compound 48/80 treated 0% 0% 
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ratio remained relatively higher, suggesting a contrasting 
effect of thyroid hormone on cardiac muscle compared with 
skeletal muscle (Fig. 4. 1). These observations are similar 
to those reported by Carter~~ (1980), who additionally 
measured protein breakdown by means of pulse labelling studies 
in myofibrillar and sarcoplasmic fractions of skeletal and 
cardiac muscles of hyperthyroid rats. They found that the 
skeletal muscle fractions had increased breakdown rates, while 
cardiac muscle fractions had decreased or normal rates. 
4.3.2. In vitro enzyme activities 
Compared with control rats, mast cell degranulation resulted 
in a marked decrease (> 90 %) in chymase activity (Table 4.2), 
while the high molecular weight protease activity remained 
unchanged (Table 4.3). Not only was this confirmatory 
evidence for the mast cell location of chymase, but these 
observations also indicated that the high molecular weight 
protease was of myocytic origin. 
Measurement of chymase and high molecular weight protease 
activities in the various myopathic groups (diabetes mellitus, 
hyperthyroidism, denervation and starvation) revealed no 
difference in these activities from those observed in muscles 
derived from control rats (Tables 4.2 and 4.3). 
Although Mayer and Shafrir (1974) noted that starvation 
caused an increase in 'myofibril associated alkaline protease' 













































































































































































































































































4 days; in contrast, we noted that 2 days of starvation 
was already associated with increased in situ proteolysis, 
but not with changed chymase activity. 
In the case of the high molecular weight protease, it was 
observed during its characterization (see Chapter 3) that 
the column treated HSSN fraction revealed a linear relation-
ship with increasing protein concentration, whereas the activ-
ity in the relatively unpurified HSSN did not behave in this 
(desirable) way. For this reason, in this comparative 
study, the Sepharose 68-treated material was pooled and com-
pared, looking both at total and specific activities in the 
various groups tested. Both these parameters of activity 
did not change in parallel with enhanced~ situ rates of 
proteolysis, implying that if one were to postulate a role 
for the high molecular weight protease in the pathway of 
protein degradation, it would have to assume one that was 
not rate-limiting for the overall degradative process 
(unless the concentrations of some critical and specific 
inhibitors were changing in these various states). 
4.4. DISCUSSION 
Rates of in situ proteolysis of intact soleus and EDL muscles 
were the same in controls and in rats subjected to mast cell 
degranulation. In addition, the extent of inhibition of 
proteolysis by known protease inhibitors (chymostatin and 
leupeptin) was of the same order in these two groups, while 
chymase activity had fallen markedly in the treated animals -
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confirming earlier reports (Libby and Goldberg, 1980). 
These observations suggested that the overall degradative 
process {from intact proteins to the level of amino aicds) 
was not limited by the activity of the mast cell protease. 
Furthermore, we have observed that denervation in rats in 
whom the mast ce]s have been degranulated showed a similar 
enhancement of proteolysis as that observed in normal rats 
undergoing denervation - showing that the mast cell protease 
is not a limiting factor in altered states of proteolysis. 
The activity levels of chymase were similar in all groups 
studied (with the exception of the mast cell degranulated 
group), revealing the lack of correlation between chymase 
activity and altered proteolytic states - a feature of a 
non-participant or a non-regulatory protease. 
Similar activity levels of the high molecular weight 
protease were detected in muscles derived from rats subjected 
to mast cell degranulation and .controls, suggesting a myo-
cytic origin of this enzyme. The lack of correlation bet-
ween altered in situ rates and the activity of this protease 
I 
suggest that this protease is not rate-limiting for proteo-
lytic processes. However, similarities between this 
protease and that of the reticulocyte system (Hershko et~' 
1980) not only suggest that this enzyme may form part of a 
similar multi-component ATP-dependent system in muscle, but 
furthermore indicate that the regulatory factor(s) in protein 
degradation may only become more apparent as greater insight 
is gained into the components participating in the pathway 
150 
of protein degradation. The characterization of a mechan-
istic pathway in muscle protein degradation on the lines of 
the reticulocyte system (Hershko ~ ~' 1980), holds the 
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Rat skeletal muscle homogenates contained an easily sedi-
mented, chymostatin-sensitive protease(s) which acted on 
associated myofibrillar proteins at an optimum pH of 8.5. 
This action was less rapid at low than at high ionic strength, 
when myosin heavy chains were cleaved with the formation of 
heavy and light meromyosin-like fragments. The protease 
also acted on protein substrates present in the particle-
free cytosol fraction of the muscle extracts, but this 
activity was more pronounced at low ionic strength (filamen-
tous form of the myofibrillar proteins). 
Inhibitor(s) of the proteinase were apparently present in 
the cytosol fraction; these did not act on the filamentous 
form of the enzyme, but were effective at high ionic strength 
when all the myofibrillar (and associated) proteins were in 
solution. 
The enzyme was separated from the bulk of the myofibrillar 
proteins by gel chromatography at high ionic strength. On 
dialysis against a buffer at low ionic strength, part of the 
enzyme was precipitated. The putative cytosolic inhibitors 
were again only effective on the soluble enzyme at high ionic 
strength. 
The proteinase activity virtually disappeared from the muscles 
of animals treated with the mast cell degranulator, compound 
48/80. Furthermore, the rates of proteolysis in intact 
153 
soleus and extensor digitorum (EDL) muscles obtained from 
the same treated rats were not different from those found 
in muscles of matched controls. Extracts from a line of 
cultured skeletal muscle cells did not show such an enzyme 
activity in the particulate myofibrillar fraction. 
Starvation, denervation and the induction of hyperthyroidism 
and diabetes mellitus in the laboratory rats, yielded muscles 
that displayed increased protein degradation, but these states 
were not associated with changes in the activity level of the 
myofibril-associated protease. This enzyme thus appeared to 
be the mast cell 11 chymase 11 , released during homogenization of 
the muscle tissue, and was not of myocytic origin. However, 
its properties when associated with the myofibrils and when 
in free solution, present a model for the differential control 
of cellular proteinases by inhibitors whose effectiveness can 
be modulated by variable supramolecular structure. 
Although the role of the mast cell in health and disease 
remains poorly understood (Pepys and Edwards, 1979), the 
data presented here indicate that the mast cell chymase is 
an unlikely participatant in proteolysis within muscle cells. 
Nevertheless, recent reports illustrating the possible syner-
gism between chymase and calcium activated protease..!.!!. vitro 
(Kay et~, 1981), suggest that chymase may still be a 
possible candidate for intracellular proteolysis and there-
fore further knowledge into precise biochemical events in the 
pathway of protein degradation remains to be obtained in order 
to credit this protease with its relevant function(s). 
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A cytosolic enzyme which attacks native or denatured proteins 
(casein, globin, hexokinase, mixed myofibrillar proteins) was 
detected and purified about 5000-fold from various rat skeletal 
muscles, including muscles freed of mast cells by prior treat-
ment of the animals with the degranulator, compound 48/80. 
Peptides of varying size were generated from radio-actively 
labelled globin, but no free amino acids were formed; free 
tyrosine was also not released from azocasein. The pH optimum 
was 7,5 and the presence of an essential thiol group was sug-
gested because dithiothreitol stimulated the activity and 
N-ethylmaleimide and parachloromercuriphenylsulphonic acid 
were inhibitors. The activity was markedly inhibited by Zn++ 
but not by leupeptin, chymostatin or pepstatin. The enzyme 
was stabilized by ATP, at concentrations as low as 0, 1 mM, 
against inactivation at 42°c. The apparent molecular mass 
estimated by gel filtration was 500000 and SDS-polyacrylamide 
gel electrophoretic analysis of the partially purified enzyme 
showed that two subunits with approximate molecular weights 
of 100000 and 52000 represented most of the protein. 
The endoprotease was clearly separated on gel chromatography 
from another large protease, also sensitive to Zn++, but with 
marked aminopeptidase activity and the properties of Hydrolase 
H (Okitani ~ ~' 1981). 
No evidence for a ubiquitin cofactor in skeletal muscle was 
found; partially purified erythrocyte ubiquitin also did not 
produce ATP-dependence of the activity of the high molecular 
mass protease, at any level of purification. 
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The activity levels of the protease, assayed after chromato-
graphy on Sepharose 68 of high-speed supernatant fractions, 
did not vary significantly in skeletal muscle samples which 
were derived from denervated, starved, diabetic or hyper-
thyroid animals, in all of which the abnormal physiological 
states expressed themselves as enhanced rates of tyrosine 
release by incubated soleus and EDL muscles. Nevertheless, 
the enzyme described here may be part of an ATP-dependent, 
mu l ti - component p rote o l y t i c sys t em , s i mi l a r to th at a l re a dy 
known to be present in reticulocytes. 
The results presented here, suggest that this macroprotease 
is of myocytic origin andtne lack of correlation of this 
activity with altered rates of proteolysis further indicate 
that this enzyme is not rate-limiting for the overall process 
of intracellular protein degradation. However, in terms of 
present pathway models, the role of this high molecular weight 
protease in intracellular protein degradation would be that 
of an extralysosomal non-regulatory protease. 
The observation that physiological manipulation in vivo in-
fluences measured rates of proteolysis .i.!!. vitro confirms 
previous reports, and in this regard an interesting hormonal 
effect is that of thyroid hormone. Thyroid hormones at 
physiological levels are necessary for growth, while the same 
in excess result in muscle wasting (Goldberg, 1980). With 
regard to the latter, whi·le skeletal muscles atrophy and dis-
play enhanced proteolytic rates, cardiac muscle undergoes 
hypertrophy (Carter~.!.}_, 1980) - an observation which has 
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been confirmed in this work. A change in cardiac myosin 
heavy chain isozyme distribution in response to thyroid 
hormone (Hoh~.!}_, 1977; Sartore~.!}_, 1981) represents 
a model whereby thyroid hormones can initiate a switch in 
protein synthesis at a nuclear level accounting for the 
clinical effects of the hyperthyroid state. Further studies 
on a similar design examining skeletal muscles of hyper-
thyroid animals may well add clarification towards the con-
trasting effects of excess thyroid hormone on cardiac and 
skeletal muscles. The specific rate-limiting biochemical 
event(s) that are influenced by the endocrine system remains 
one challenging area in protein turnover research that holds 
the promise for the identification of appropriate therapy 





The skeletal muscle cell is composed of a number of sub-
cellular compartments in which proteins in both particulate 
and soluble forms undergo differential rates of turnover. 
Several explanations for the overall function of continuous 
intracellular protein degradation have been proposed (Gold-
berg and Dice, 1974; Goldberg and St John, 1976; Ballard, 
1977), but their significance remains uncertain. A central 
suggestion appears to be that turnover may facilitate the 
adaptation of the organism to its environment. In addition, 
adaptation to poor environments may require protein degrada-
tion simply to provide energy and sufficient amino acid pre-
cursors for the synthesis of those proteins which are required 
(such as catabolic enzymes). Another important function of 
protein degradation may be the removal of abnormal (defective) 
proteins produced as a result of exogenous (mutagens) or 
endogenous (biosynthetic error) factors. 
There have been several difficult key questions posed to in-
vestigators in the study of skeletal muscle protein degradation. 
One of these is the significance of the differential turnover 
rates of the numerous cellular proteins in their native state. 
A second major unresolved puzzle is how the 11 ageing 11 of a 
protein renders it "abnormal" and thus marked as a susceptible 
substrate for the intracellular degradative machinery. The 
energy-dependent multi-componentsystem in reticulocytes as 
described by Hershko and co-workers (Hershko ~ ~, 1979; 
b 
Ciechanover, ~ ~' 1980) is one in which the denatured state 
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of substrate protein is a pre-requirement for this mechanism 
to be operative. The chemistry of this "ageing abnormality" 
may be mediated by processes such as methylation, phosphory-
lation or de-amidation. Support for such chemical modifica-
tion resulting in an enhanced susceptibiiity of proteins to 
protease digestion has already been described by several 
independent investigators (Bohley et~' 1981; Pace~~' 
1981, and Holzer, 1981). Against this 11 ageing 11 model is 
the "first order 11 model of the fate of intracellular proteins 
in which the random fate of all molecules (young or old) is 
the same. The two models need not necessarily be in oppo-
sition to each other as the 11 ageing 11 phenomenon could be a 
first order process, i.e. any protein molecule could age at 
any moment. 
The third question awaiting an answer is how many differing 
pathways are present (viz. lysosomal, with or without auto-
phagy, and non-lysosomal, energy-dependent and energy-
independent) and how these may be inter-related in cellular 
proteolysis. 
The fourth problem concerns the site of flux-generating step(s). 
The answer to this would make possible important advances in 
terms of knowledge of the physiology of protein degradation 
as well as specific therapy for muscle-diseased states. The 
altered rates of in-situ muscle proteolysis in response to 
changes in the hormonal status of experimental animals suggests 
that the well-known endocrine myopathies in human patients are 
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mediated by hormones acting at flux-generating reaction 
steps along the pathway. Hormones could result in regula-
tion of absolute levels of proteases by activation-inactiva-
tion steps or by altering levels of endogenous inhibitors. 
Inhibitor effect could be modulated by changes in absolute 
inhibitor concentration, activation-inactivation chemical 
interconversions, or possibly even an extra-cellular source 
of specific protease inhibitors. Mammalian serum which con-
tains several anti-proteases (Laskowski and Kato, 1980) is 
a potential source of extracellular regulators of muscle 
proteolysis in muscle injury or inflammation and other myo-
pathic states. A number of investigators have demonstrated 
elevated activity levels of several proteases in muscle ex-
tracts from humans afflicted with muscular dystrophies (for 
review, see Kar and Pearson, 1980). However, as some of 
these proteases were muscle-cell derived while others were 
of non-muscle cell origin, the significance of these observa-
tions in terms of the regulation of proteolysis in muscle 
disease is unknown at present (Dahlmann ~ ~, 1981b). 
Finally, in addition to understanding the biochemical details 
of the homeostatic mechanisms within muscle fibres which 
serve to maintain a steady state of protein catabolism, the 
process by which protein synthesis is coordinated with deg-
radation to maintain protein equilibrium is yet another area 
which awaits clarification. 
These are all difficult questions and further experimental 
161 
work will be required to incorporate the present knowledge 
with the new in order to arrive at a composite mechanistic 
picture of the intracellular degradative system. 
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